<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Saline irrigation for allergic rhinitis - Head, K - 2018 | Cochrane Library</title> <meta content="Saline irrigation for allergic rhinitis - Head, K - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012597.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Saline irrigation for allergic rhinitis - Head, K - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012597.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012597.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Saline irrigation for allergic rhinitis" name="citation_title"/> <meta content="Karen Head" name="citation_author"/> <meta content="Nuffield Department of Surgical Sciences, University of Oxford" name="citation_author_institution"/> <meta content="khead@cochrane.org" name="citation_author_email"/> <meta content="Kornkiat Snidvongs" name="citation_author"/> <meta content="Chulalongkorn University" name="citation_author_institution"/> <meta content="Simon Glew" name="citation_author"/> <meta content="Brighton and Sussex Medical School" name="citation_author_institution"/> <meta content="Glenis Scadding" name="citation_author"/> <meta content="Royal National Throat, Nose &amp; Ear Hospital" name="citation_author_institution"/> <meta content="Anne GM Schilder" name="citation_author"/> <meta content="Faculty of Brain Sciences, University College London" name="citation_author_institution"/> <meta content="Carl Philpott" name="citation_author"/> <meta content="Claire Hopkins" name="citation_author"/> <meta content="Guy's Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD012597.pub2" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/06/22" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012597.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012597.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012597.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Intranasal; Adrenal Cortex Hormones [administration &amp; dosage]; Histamine Antagonists [administration &amp; dosage]; Nasal Sprays; Randomized Controlled Trials as Topic; Rhinitis, Allergic [*therapy]; Sodium Chloride [*administration &amp; dosage, adverse effects]; Therapeutic Irrigation [adverse effects, methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012597.pub2&amp;doi=10.1002/14651858.CD012597.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="qy4lqFNF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012597\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012597\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ru","ms","ja","fr","pl","de","hr","fa","th","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012597.pub2",title:"Saline irrigation for allergic rhinitis",firstPublishedDate:"Jun 22, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane ENT Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=qy4lqFNF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012597.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012597.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012597.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012597.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012597.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012597.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012597.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012597.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012597.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012597.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>22159 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012597.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-sec-0178"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-sec-0078"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-sec-0167"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/appendices#CD012597-sec-0190"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/table_n/CD012597StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/table_n/CD012597StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Saline irrigation for allergic rhinitis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#CD012597-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Karen Head</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#CD012597-cr-0003">Kornkiat Snidvongs</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#CD012597-cr-0004">Simon Glew</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#CD012597-cr-0005">Glenis Scadding</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#CD012597-cr-0006">Anne GM Schilder</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#CD012597-cr-0007">Carl Philpott</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information#CD012597-cr-0008">Claire Hopkins</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information/en#CD012597-sec-0194">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 22 June 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012597.pub2">https://doi.org/10.1002/14651858.CD012597.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012597-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012597-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012597-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012597-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012597-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD012597-abs-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012597-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012597-abs-0001" lang="en"> <section id="CD012597-sec-0001"> <h3 class="title" id="CD012597-sec-0001">Background</h3> <p>Allergic rhinitis is a common condition affecting both adults and children. Patients experience symptoms of nasal obstruction, rhinorrhoea, sneezing and nasal itching, which may affect their quality of life. </p> <p>Nasal irrigation with saline (salty water), also known as nasal douching, washing or lavage, is a procedure that rinses the nasal cavity with isotonic or hypertonic saline solutions. It can be performed with low positive pressure from a spray, pump or squirt bottle, with a nebuliser or with gravity‐based pressure in which the person instils saline into one nostril and allows it to drain out of the other. Saline solutions are available over the counter and can be used alone or as an adjunct to other therapies. </p> </section> <section id="CD012597-sec-0002"> <h3 class="title" id="CD012597-sec-0002">Objectives</h3> <p>To evaluate the effects of nasal saline irrigation in people with allergic rhinitis.</p> </section> <section id="CD012597-sec-0003"> <h3 class="title" id="CD012597-sec-0003">Search methods</h3> <p>The Cochrane ENT Information Specialist searched the ENT Trials Register; CENTRAL; Ovid MEDLINE; Ovid Embase; CINAHL; Web of Science; ClinicalTrials.gov; ICTRP and additional sources for published and unpublished trials. The date of the search was 23 November 2017. </p> </section> <section id="CD012597-sec-0004"> <h3 class="title" id="CD012597-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) comparing nasal saline irrigation, delivered by any means and with any volume, tonicity and alkalinity, with (a) no nasal saline irrigation or (b) other pharmacological treatments in adults and children with allergic rhinitis. We included studies comparing nasal saline versus no saline, where all participants also received pharmacological treatment (intranasal corticosteroids or oral antihistamines). </p> </section> <section id="CD012597-sec-0005"> <h3 class="title" id="CD012597-sec-0005">Data collection and analysis</h3> <p>We used the standard methodological procedures expected by Cochrane. Primary outcomes were patient‐reported disease severity and a common adverse effect ‐ epistaxis. Secondary outcomes were disease‐specific health‐related quality of life (HRQL), individual symptom scores, general HRQL, the adverse effects of local irritation or discomfort, ear symptoms (pain or pressure) and nasal endoscopy scores. We used GRADE to assess the quality of the evidence for each outcome; this is indicated in <i>italics</i>. </p> </section> <section id="CD012597-sec-0006"> <h3 class="title" id="CD012597-sec-0006">Main results</h3> <p>We included 14 studies (747 participants). The studies included children (seven studies, 499 participants) and adults (seven studies, 248 participants). No studies reported outcomes beyond three months follow‐up. Saline volumes ranged from 'very low' to 'high' volume. Where stated, studies used either hypertonic or isotonic saline solution. </p> <p><b>Nasal saline <i>versus</i> no saline treatment</b> </p> <p>All seven studies (112 adults; 332 children) evaluating this comparison used different scoring systems for <b>patient‐reported disease severity</b>, so we pooled the data using the standardised mean difference (SMD). Saline irrigation may improve patient‐reported disease severity compared with no saline at up to four weeks (SMD ‐1.32, 95% confidence interval (CI) ‐1.84 to ‐0.81; 407 participants; 6 studies; <i>low quality</i> ) and between four weeks and three months (SMD ‐1.44, 95% CI ‐2.39 to ‐0.48; 167 participants; 5 studies; <i>low quality</i> ). Although the evidence was <i>low quality</i> the SMD values at both time points are considered large effect sizes. Subgroup analysis showed the improvement in both adults and children. Subgroup analyses for volume and tonicity were inconclusive due to heterogeneity. </p> <p>Two studies reported methods for recording adverse effects and five studies mentioned them. Two studies (240 children) reported no <b>adverse effects</b> (epistaxis or local discomfort) in either group and three only reported no adverse effects in the saline group. </p> <p>One study (48 children) reported <b>disease‐specific HRQL</b> using a modified RCQ‐36 scale. It was uncertain whether there was a difference between the groups at any of the specified time points (<i>very low quality</i>). No other secondary outcomes were reported. </p> <p><b>Nasal saline <i>versus</i> no saline with adjuvant use of intranasal steroids or oral antihistamines</b> </p> <p>Three studies (40 adults; 79 children) compared saline with intranasal steroids versus intranasal steroids alone; one study (14 adults) compared saline with oral antihistamines versus oral antihistamines alone. It is uncertain if there is a difference in <b>patient‐reported disease severity</b> at up to four weeks (SMD ‐0.60, 95% CI ‐1.34 to 0.15; 32 participants; 2 studies; <i>very low quality</i> ) or from four weeks to three months (SMD ‐0.32, 95% CI ‐0.85 to 0.21; 58 participants; 2 studies; <i>very low quality</i>). Although none of the studies reported methods for recording <b>adverse effects</b> , three mentioned them: one study (40 adults; adjuvant intranasal steroids) reported no <b>adverse effects</b> (epistaxis or local discomfort) in either group; the other two only reported no adverse effects in the saline group. </p> <p>It is uncertain if saline irrigation in addition to pharmacological treatment improved <b>disease‐specific HRQL</b> at four weeks to three months, compared with pharmacological treatment alone (SMD ‐1.26, 95% CI ‐2.47 to ‐0.05; 54 participants; 2 studies; <i>very low quality</i>). No other secondary outcomes were reported. </p> <p><b>Nasal saline <i>versus</i> intranasal steroids</b> </p> <p>It is uncertain if there was a difference in <b>patient‐reported disease severity</b> between nasal saline and intranasal steroids at up to four weeks (MD 1.06, 95% CI ‐1.65 to 3.77; 14 participants; 1 study), or between four weeks and three months (SMD 1.26, 95% CI ‐0.92 to 3.43; 97 participants; 3 studies), or in<b>disease‐specific HRQL</b> between four weeks and three months (SMD 0.01, 95% CI ‐0.73 to 0.75; 83 participants; 2 studies). Only one study reported methods for recording <b>adverse effects</b> although three studies mentioned them. One (21 participants) reported two withdrawals due to adverse effects but did not describe these or state which group. Three studies reported no <b>adverse effects</b> (epistaxis or local discomfort) with saline, although one study reported that 27% of participants experienced local discomfort with steroid use. No other secondary outcomes were reported. </p> </section> <section id="CD012597-sec-0007"> <h3 class="title" id="CD012597-sec-0007">Authors' conclusions</h3> <p>Saline irrigation may reduce patient‐reported disease severity compared with no saline irrigation at up to three months in both adults and children with allergic rhinitis, with no reported adverse effects. No data were available for any outcomes beyond three months. The overall quality of evidence was <i>low</i> or <i>very low.</i> The included studies were generally small and used a range of different outcome measures to report disease severity scores, with unclear validation. This review did not include direct comparisons of saline types (e.g. different volume, tonicity). </p> <p>Since saline irrigation could provide a cheap, safe and acceptable alternative to intranasal steroids and antihistamines further high‐quality, adequately powered research in this area is warranted. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012597-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012597-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012597-abs-0013">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012597-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012597-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012597-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD012597-abs-0014">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012597-abs-0009">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012597-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012597-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012597-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD012597-abs-0018">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012597-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012597-abs-0019">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012597-abs-0005" lang="en"> <h3>Nasal saline for allergic rhinitis</h3> <p><b>Background</b> </p> <p>Allergic rhinitis is inflammation (swelling and/or irritation) of the inside of the nose caused by allergies. It is common in both children and adults. Allergic rhinitis can be intermittent (fewer than four days per week, or four weeks per year) or persistent (more than four days per week, or four weeks per year). The allergy can be caused by many different things but common allergens (things causing allergy) are: grass or tree pollen, mould, dust mites or animal dander (tiny flakes of skin). People with allergic rhinitis experience symptoms (nasal obstruction, runny nose, nasal itching and sneezing) that may affect their quality of life. </p> <p>Nasal saline irrigation (also known as nasal douche, wash or lavage) is a procedure that rinses the nasal cavity with saline (salt water) solutions. How saline works is not fully understood but it is probably through making the mucus (snot) thinner, making it easier to remove and also removing some of the allergens from the nose that cause irritation. Nasal saline irrigation can be performed with sprays, pumps or squirt bottles. Saline solutions can be isotonic (the same concentration of salt that is found in the body ‐ 0.9% NaCl) or hypertonic (more salty than found in the body ‐ more than 0.9% NaCl). Although saline irrigation is thought to be safe there have been reports of epistaxis (nosebleeds) and irritation or discomfort in the nose and ears. This therapy is available without prescription and can be used alone or as an add‐on to other pharmacological treatment for allergic rhinitis, such as intranasal (in the nose) steroids and oral antihistamines). </p> <p><b>Search date</b> </p> <p>The evidence is up to date to November 2017.</p> <p><b>Study characteristics</b> </p> <p>We found 14 studies with a total of 747 participants (260 adults; 487 children). The volume of saline used in the studies varied: five studies used 'very low' volumes (nasal sprays providing less than 5 mL saline per nostril per application), two studies used low‐volume (between 5 and 59 mL saline per nostril per application introduced with a syringe) and four studies used high‐volume solutions (more than 60 mL per nostril per application). Eight studies used hypertonic saline, five used isotonic saline and three studies did not provide this information. Two studies used two different types of saline solutions. </p> <p><b>Study funding sources</b> </p> <p>Seven studies did not say how they were funded. The other seven were funded either by the investigators' department or research grants from regional or national government. No studies were funded by pharmaceutical companies. </p> <p><b>Key results</b> </p> <p><i>Nasal saline irrigation compared with no saline irrigation</i> </p> <p>Nasal saline irrigation may have benefits in both adults and children in relieving the symptoms of allergic rhinitis compared to no saline irrigation and it is unlikely to be associated with adverse effects. It is not possible to tell from this review whether there is a difference between the different volumes and concentrations of saline solution. </p> <p><i>Adding nasal saline irrigation onto 'pharmacological' allergic rhinitis treatment</i> </p> <p>It is uncertain whether adding nasal saline irrigation to pharmacological treatment (intranasal steroids or oral antihistamines) helps to improve the symptoms of allergic rhinitis compared to using pharmacological treatments alone. The use of nasal saline irrigation is unlikely to be associated with adverse effects. </p> <p><i>Nasal saline irrigation compared to 'pharmacological' allergic rhinitis treatment</i> </p> <p>There is not enough evidence to know whether nasal saline irrigation is better, worse or the same as using intranasal steroids. No studies reporting the outcomes we were interested in compared nasal saline irrigation with oral antihistamines. </p> <p><b>Quality of evidence</b> </p> <p>The overall quality of evidence for nasal saline irrigation compared with no saline treatment was either<i>low quality</i> (our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect) or <i>very low quality</i> (we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect). This was because the studies were mostly very small and used different methods to measure the same outcome. Since saline irrigation could provide a cheap, safe and acceptable alternative to intranasal steroids and antihistamines further high‐quality studies are needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012597-sec-0178" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012597-sec-0178">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012597-sec-0248">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012597-sec-0178"></div> <h3 class="title" id="CD012597-sec-0179">Implications for practice</h3> <section id="CD012597-sec-0179"> <section id="CD012597-sec-0180"> <h5 class="title">For people with allergic rhinitis</h5> <p>There is <i>low‐quality evidence</i> that nasal saline irrigation may have benefits in both adults and children in relieving symptoms of allergic rhinitis compared to no saline treatment. The use of nasal saline irrigation is unlikely to be associated with adverse effects. It is unclear which is the best type of saline irrigation to use with respect to volume, strength and how often to use it. </p> </section> <section id="CD012597-sec-0181"> <h5 class="title">For clinicians</h5> <p>There is <i>low‐quality evidence</i> that using saline irrigation may reduce patient‐reported disease severity compared with no saline treatment at up to four weeks and between four weeks and three months in both adults and children. The reporting of adverse effects in the studies was very poor but no studies reported adverse effects with the use of saline. This review did not look at direct comparisons of saline type (e.g. volume, tonicity and frequency of administration). No longer‐term outcomes (after three months) were identified. There is a lack of evidence to compare saline irrigation to pharmacological treatments. </p> </section> <section id="CD012597-sec-0182"> <h5 class="title">For funders</h5> <p>Although saline may be an effective treatment for reducing symptoms of allergic rhinitis (<i>low‐quality evidence</i>), there is generally a lack of information about its use. Further research is needed: this may include both systematic reviews comparing types of saline (volume, tonicity, frequency of administration), as we excluded 15 studies from this review that made these comparisons, and well‐conducted primary trials (see <a href="#CD012597-sec-0183">Implications for research</a>). </p> </section> </section> <h3 class="title" id="CD012597-sec-0183">Implications for research</h3> <section id="CD012597-sec-0183"> <section id="CD012597-sec-0184"> <h5 class="title">Evidence</h5> <p>As of November 2017, we have identified 14 studies that investigated the use of nasal saline irrigation in allergic rhinitis. The studies were generally small (median sample size = 46 participants) and poorly reported. The evidence identified indicates that there may be benefits in terms of patient‐reported disease severity when compared with no saline treatment but the range of unvalidated instruments used, along with heterogeneity in the study characteristics, made it difficult to draw definite conclusions. The reporting of adverse effects was very poor in the studies. </p> <p>We consider that more research on the use of nasal saline in allergic rhinitis is very important. We propose that the following aspects should be considered when designing trials: </p> </section> <section id="CD012597-sec-0185"> <h5 class="title">Population</h5> <p> <ul id="CD012597-list-0030"> <li> <p>Separate trials should be completed <b>in children and in adults</b> as the setting for recruitment and the outcomes are likely to be different. </p> <ul id="CD012597-list-0031"> <li> <p>Children should be recruited from <b>secondary care clinics</b> where better diagnostic testing is available and recruitment is likely to be easier. </p> </li> <li> <p>Adults could be recruited into large, multicentre, <b>primary care</b> trials, although appropriate diagnosis testing should be a prerequisite. </p> </li> </ul> </li> <li> <p>Trials should be <b>adequately powered</b> and imbalances in prognostic factors (for example, allergen type) must be accounted for in the statistical analysis. </p> </li> <li> <p>Study participants should be<b>diagnosed</b> with allergic rhinitis using appropriate diagnostic methods including clinical symptoms characteristic of allergic rhinitis with a positive radioallergosorbent test (RAST) or skin prick test (SPT). </p> </li> </ul> </p> </section> <section id="CD012597-sec-0186"> <h5 class="title">Intervention and comparison</h5> <p> <ul id="CD012597-list-0032"> <li> <p>Any trial should be pragmatic and consider the use of <b>saline irrigation as an adjunct to pharmacological treatments</b> (such as intranasal steroids and antihistamines). </p> </li> <li> <p>In adults in primary care, a trial of <b>saline irrigation compared with intranasal corticosteroids</b> could be considered. </p> </li> <li> <p>Investigators should consider the <b>volume, tonicity, alkalinity, temperature and frequency of administration</b> of the saline irrigation used. </p> </li> <li> <p>If people with seasonal allergic rhinitis are included within the trial, it should be conducted at a time of the year when symptoms are expected to occur. All trials should be completed for a <b>sufficient duration</b> to determine whether continued use of saline nasal irrigation has additional benefits or harms. Studies should consider investigating the effect of longer‐term use of nasal saline (e.g. more than six months). </p> </li> </ul> </p> </section> <section id="CD012597-sec-0187"> <h5 class="title">Outcomes</h5> <p> <ul id="CD012597-list-0033"> <li> <p>Studies should focus on outcomes that are important to people with allergic rhinitis and use <b>validated instruments</b> to measure these, in particular using standard, validated, patient‐reported disease severity scores and disease‐specific health‐related quality of life scores. People may find dichotomised outcomes easiest to interpret; for example, the percentage of participants achieving a minimal clinically important difference (MCID) or improvement for that outcome. Such MCIDs or cut‐off points should be included in the study protocol and clearly outlined in the methods section. </p> </li> <li> <p><b>Adverse effects</b> should be defined at the start of the trial and methods for reporting these should be clearly stated in the protocol. </p> </li> <li> <p>Symptom scores should include both <b>nasal and ocular symptoms</b> (such as eye redness and eye itching) as many people will experience these with allergic rhinitis. </p> </li> <li> <p>The <b>duration</b> of the trial needs to be carefully considered. The current evidence only includes trials that had up to a three‐month treatment duration. There are still unanswered questions about the benefits and harms of long‐term use of nasal saline for persistent allergic rhinitis. </p> </li> <li> <p>Trials and other high‐quality studies should use <b>consistent outcomes</b> and <b>adhere to reporting guidelines</b>, such as CONSORT, so that results can be compared across future trials. The development of a standardised set of outcomes, or core outcome set, for allergic rhinitis, agreed by researchers, clinicians and patients, will facilitate this process. </p> </li> </ul> </p> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012597-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012597-sec-0043"></div> <div class="table" id="CD012597-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Saline versus no saline treatment for allergic rhinitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Saline versus no saline treatment for allergic rhinitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> allergic rhinitis </p> <p><b>Setting:</b> secondary care<br/> <b>Intervention:</b> saline<br/> <b>Comparison:</b> no saline treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>What happens</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Without saline</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>With saline</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Difference</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease severity score (up to 4 weeks)</p> <p>Assessed with: various instruments<br/> Follow‐up: range 1 week to 4 weeks<br/> № of participants: 407 </p> <p>(322 children; 85 adults)<br/> (6 RCTs) <sup>2</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.32 lower<br/> (1.84 lower to 0.81 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline irrigation may improve the patient‐reported disease severity compared with no saline treatment in both children and adults. The mean difference in disease severity score was 1.32 standard deviations lower (1.84 to 0.81 lower) with saline compared to no saline. This translates into a decrease of approximately 1.97 points (1.21 to 2.74) on a 0‐ to 10‐point VAS for nasal symptoms (lower = better). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease severity score (4 weeks to 6 months)</p> <p>Assessed with: various instruments<br/> Follow‐up: range 6 weeks to 8 weeks<br/> № of participants: 167 </p> <p>(102 children; 65 adults)<br/> (5 RCTs) <sup>2</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.44 lower<br/> (2.39 lower to 0.48 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline irrigation may improve the patient‐reported disease severity compared with no saline treatment in both children and adults. The mean difference in disease severity score was 1.44 standard deviations lower (2.39 to 0.489 lower) with saline compared to no saline. This translates into a decrease of approximately 2.98 points (0.99 to 5.98) on a 0‐ to 10‐point VAS for nasal symptoms (lower = better). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual symptom scores ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Epistaxis<br/> Follow‐up: range 4 weeks to 6 weeks<br/> № of participants: 240 (all children)<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Not pooled</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2 studies (240 children) reported no adverse effects in either arm. Both studies included only children. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific HRQL</p> <p>Assessed with: RCQ‐36 quality of life questionnaire<br/> Scale from: 0 to 140, lower = better<br/> Follow‐up: 4 weeks<br/> № of participants: 42 (all children)<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease specific HRQL ‐ Up to 4 weeks without saline was 19.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.32 lower<br/> (11.35 lower to 4.71 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline improves the disease‐specific quality of life at 4 weeks, compared with no saline, because the quality of the evidence is very low. The study included only children. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific HRQL ‐ 4 weeks to 6 months<br/> Assessed with: RCQ‐36<br/> Scale from: 0 to 140<br/> follow‐up: 6 weeks<br/> № of participants: 42 (all children)<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease specific HRQL ‐ 4 weeks to 6 months without saline was 15.94</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.06 lower<br/> (8.38 lower to 4.26 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline improves the disease‐specific quality of life at 6 weeks, compared with no saline, because the quality of the evidence is very low. The study included only children. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Other adverse effects: local irritation<br/> Follow‐up: range 4 weeks to 6 weeks<br/> № of participants: 240 (all children)<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Not pooled</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2 studies (240 children) reported no adverse effects in either arm. 3 further studies (68 children; 44 adults) reported no adverse effects in the saline arm. There is no information for the control arm. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>HRQL:</b> health‐related quality of life; <b>MD:</b> mean difference; <b>RCQ‐36:</b> Thai rhinoconjunctivitis quality of life scale; <b>RCT:</b> randomised controlled trial; <b>SMD:</b> standardised mean difference; <b>VAS:</b> visual analogue scale </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Low‐quality evidence. Downgraded by one level due to <b>risk of bias</b> (all of the studies used different scales for which the validation is unknown). Downgraded by one level due to <b>inconsistency</b> (there is statistical heterogeneity within the results possibly due to the variations in tonicity, volume and method of application of saline used). </p> <p><sup>2</sup>Different instruments were used to assess the disease severity score. A summary of these can be found in <a href="#CD012597-tbl-0004">Table 2</a>. </p> <p><sup>3</sup>Low‐quality evidence. Downgraded by two levels due to <b>risk of bias</b> (the reporting of the adverse outcomes was very poor and it was unclear whether the adverse effects were systematically sought). </p> <p><sup>4</sup>Very low‐quality evidence. Downgraded by two levels for <b>risk of bias</b> (results came from one study using an instrument for which the validation status is unknown with a high risk of performance and detection bias). Downgraded by one level for <b>imprecision</b> (the results are imprecise due to the small sample size and the confidence intervals are very wide). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012597-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Saline irrigation plus pharmacological treatment versus pharmacological treatment alone for allergic rhinitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Nasal saline plus pharmacological treatment versus pharmacological treatment alone for allergic rhinitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> allergic rhinitis </p> <p><b>Setting:</b> secondary care<br/> <b>Intervention:</b> saline plus pharmacological treatment (intranasal steroids or oral antihistamines)<br/> <b>Comparison:</b> pharmacological treatment alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>What happens</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Without saline</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>With saline</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Difference</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease severity score (up to 4 weeks)</p> <p>Assessed with: various instruments used</p> <p>Follow‐up: 4 weeks</p> <p>№ of participants: 32 (18 children; 14 adults)</p> <p>(2 RCTs)<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.6 lower</p> <p>(1.34 lower to 0.15 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline in addition to pharmacological treatment (antihistamines or steroids) improves patient‐reported severity scores at 4 weeks, compared with pharmacological treatment alone. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease severity score (4 weeks to 6 months)<br/> Assessed with: various instruments used<br/> Follow‐up: 3 months<br/> № of participants: 58 (18 children; 40 adults)<br/> (2 RCTs) <sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.32 lower</p> <p>(0.85 lower to 0.21 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline in addition to pharmacological treatment (antihistamines or steroids) improves patient‐reported severity scores at 3 months, compared with pharmacological treatment alone. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual symptom scores ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects ‐ epistaxis</p> <p>№ of participants: 58 (2 RCTs)</p> <p>(18 children; 40 adults)</p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Three studies made statements about adverse effects. One study (40 adults) indicated that "<i>all [treatments were] tolerated well, none [of the participants] had adverse events</i>" (<a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>) and the other two studies (62 children) reported that nasal irrigation with saline was well accepted in all patients and no adverse effect was reported with the use of saline (<a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether there is a difference in adverse effects between the groups. None of the studies specifically mentioned epistaxis as an adverse effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life (4 weeks to 6 months)</p> <p>Assessed with: various instruments</p> <p>№ of participants: 54 (all adults)</p> <p>(2 RCTs)<sup>4</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.26 lower</p> <p>(2.47 lower to 0.05 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline in addition to pharmacological treatment (antihistamines or steroids) improves health‐related quality of life at 4 weeks to 6 months, compared with pharmacological treatment alone. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other adverse effects: local irritation<br/> Follow‐up: range 4 weeks to 6 weeks<br/> № of participants: 58 (18 children;40 adults)<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>None of the studies specifically mentioned local irritation as an adverse effect. Two studies made statements about adverse effects. One study (40 adults) indicated that "<i>all [treatments were] tolerated well, none [of the participants] had adverse events</i>" (<a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>) and the other (18 children) that "<i>Nasal irrigation with saline was well accepted in all patients and no adverse effect was reported</i>” (<a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether there is a difference in adverse effects between the groups as no adverse effects were reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>SMD:</b> standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Different instruments were used to assess the disease severity score. A summary of these can be found in <a href="#CD012597-tbl-0004">Table 2</a>. </p> <p><sup>2</sup> Very low‐quality evidence. Downgraded by two levels due to <b>risk of bias</b> (studies were generally poorly conducted with a high risk of bias; the validation status of the symptom severity scores used is unknown). Downgraded by one level due to <b>imprecision</b> (the results are imprecise with small sample sizes and wide confidence intervals). </p> <p><sup>3</sup>Very low‐quality evidence. Downgraded by two levels due to <b>risk of bias</b> (studies were generally poorly conducted with a high risk of bias and it is unclear whether adverse effects were systemically reported). Downgraded by one level due to <b>imprecision</b> (very small sample size). </p> <p><sup>4</sup><a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a> used the 'Global Impact' score for the Rhinasthma quality of life instrument. <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> used the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) but the range of possible scores is not reported. </p> <p><sup>5</sup>Very low‐quality evidence. Downgraded by two levels due to <b>risk of bias</b> (studies were generally poorly conducted with a high risk of bias; it is unclear whether the instruments used were validated and the scale in one remains unknown). Downgraded by one level due to <b>inconsistency</b> (there is significant statistical heterogeneity between the results). Downgraded by one level due to <b>imprecision</b> (sample size is very small and so the confidence intervals are very wide). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012597-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012597-sec-0044">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012597-sec-0203">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD012597-sec-0044"></div> <section id="CD012597-sec-0045"> <h3 class="title" id="CD012597-sec-0045">Description of the condition</h3> <p>According to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines (<a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>), allergic rhinitis is defined clinically by nasal hypersensitivity symptoms induced by an immunologically mediated (most often IgE‐dependent) inflammation of the nasal mucous membranes after exposure to an offending allergen. Common allergic triggers include house dust mites, pollens (from trees, grasses, shrubs and weeds), animal dander or fungi, which occur naturally in the environment. In addition, allergic rhinitis can be caused by triggers to which a person is exposed in the course of their work (occupational exposure). These may include vegetable proteins, enzymes and chemicals (<a href="./references#CD012597-bbs2-0053" title="ScaddingGK , KariyawasamHH , ScaddingG , MirakianR , BuckleyRJ , et al. BSACI guidelines for the management of allergic and non‐allergic rhinitis (Revised Edition 2017). Clinical and Experimental Allergy2017;47(7):856‐89. [DOI: 10.1111/cea.12953] ">BSACI 2017</a>). </p> <p>Symptoms of allergic rhinitis may include nasal obstruction (blockage or congestion), rhinorrhoea (which can be anterior leading to nasal discharge, or posterior leading to post‐nasal drip), nasal itching and sneezing (<a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). In addition to nasal symptoms, some people with allergic rhinitis also report eye symptoms (watering, redness, itching) and ear symptoms such as pain, pressure or feeling of fullness; however, aural (ear) symptoms have also been reported as an adverse effect of nasal saline irrigation (<a href="./references#CD012597-bbs2-0055" title="ChusakulS , WarathanasinS , SuksangpanyaN , PhannasoC , RuxrungthamS , SnidvongsK , et al. Comparison of buffered and nonbuffered nasal saline irrigations in treating allergic rhinitis. Laryngoscope2013;123:53‐6. ">Chusakul 2013</a>). There is evidence that people with allergic rhinitis may experience decreased quality of life due to issues such as loss of sleep, secondary daytime fatigue, impaired school and work performance, decreased cognitive functioning and decreased long‐term productivity (<a href="./references#CD012597-bbs2-0069" title="SchoenwetterWF , DupclayLJr , AppajosyulaS , BottemanMF , PashosCL . Economic impact and quality‐of‐life burden of allergic rhinitis. Current Medical Research and Opinion2004;20(3):305‐17. ">Schoenwetter 2004</a>). </p> <p>Allergic rhinitis is commonly classified into <i>'intermittent'</i> and <i>'persistent'</i> disease. Intermittent allergic rhinitis is diagnosed when symptoms are present for less than four days per week or for less than four weeks. Persistent allergic rhinitis is diagnosed when symptoms are present more frequently than four days per week and for at least four consecutive weeks (<a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). The presence of intermittent or persistent disease may be related to the type of allergic triggers for allergic rhinitis, for example intermittent allergic rhinitis may be linked to the release of a certain type of tree pollen (such as elm tree pollen) occurring once a year for a period of a few weeks. </p> <p>Prior to 2001, allergic rhinitis was classified into 'seasonal', 'perennial' and 'occupational', based on the time of exposure. Seasonal allergic rhinitis was used to define mainly 'outdoor' allergens such as tree pollens, which were not present consistently throughout the year, whereas the term 'perennial' allergic rhinitis was used for 'indoor' allergens where exposure was thought to be consistent throughout the year. The <a href="./references#CD012597-bbs2-0048" title="BousquetJ , vanCauwenbergeP , KhaltaevN . Allergic Rhinitis and Its Impact on Asthma. Journal of Allergy and Clinical Immunology2001;108(5):S147‐334. ">ARIA 2001</a> guidelines attempted to make the classification more useful in the real world by introducing the terms 'intermittent' and 'persistent' to classify the disease. The previous classification had been felt to be inadequate as it was noted that in certain situations a seasonal allergen may occur year round (e.g. grass pollen allergy in Southern California) or symptoms of perennial allergy may not always be present all year round (e.g. in the Mediterranean area where levels of house dust mite allergen are low in the summer). Thus the change to intermittent and persistent was made (<a href="./references#CD012597-bbs2-0048" title="BousquetJ , vanCauwenbergeP , KhaltaevN . Allergic Rhinitis and Its Impact on Asthma. Journal of Allergy and Clinical Immunology2001;108(5):S147‐334. ">ARIA 2001</a>). </p> <p>The ARIA guidelines further classify allergic rhinitis into 'mild' and 'moderate/severe' depending on the person's severity of symptoms and the impact of the condition on their quality of life. Moderate/severe allergic rhinitis is diagnosed when one or more of the following items are present: sleep disturbance; impairment of daily activities, leisure or sport; impairment of school or work; or troublesome symptoms (<a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). </p> <p>The diagnosis of allergic rhinitis is based upon clinical symptoms combined with laboratory studies demonstrating the presence of allergen‐specific IgE in the skin (skin prick test) or blood (serum IgE). A review of epidemiological studies estimated that 10% to 15% of adults have allergic rhinitis based on both the presence of symptoms and a positive skin prick test (<a href="./references#CD012597-bbs2-0065" title="MimsJW . Epidemiology of allergic rhinitis. International Forum of Allergy &amp; Rhinology2014;4:S18‐20. ">Mims 2014</a>). However, the number is higher when people reporting either just symptoms (up to 34%) or a positive skin prick test (up to 53.9%, testing 10 allergens) are considered (<a href="./references#CD012597-bbs2-0065" title="MimsJW . Epidemiology of allergic rhinitis. International Forum of Allergy &amp; Rhinology2014;4:S18‐20. ">Mims 2014</a>). There are a wide range of estimates for the prevalence of allergic rhinitis in children (10% to 40%). These differences in estimates may be attributable to both the geographical location of the study, the method of diagnosis used (whether a skin prick test was completed or whether the diagnosis was based on symptoms), or both (<a href="./references#CD012597-bbs2-0065" title="MimsJW . Epidemiology of allergic rhinitis. International Forum of Allergy &amp; Rhinology2014;4:S18‐20. ">Mims 2014</a>). </p> <p>Traditionally there has appeared to be a higher prevalence of allergic rhinitis in countries with a 'western lifestyle' (USA and Europe), where reported prevalence rates vary between 10% and 30% (<a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). For areas outside these regions, Katelaris et al completed a review of global prevalence studies, which identified a great diversity in the prevalence estimates of allergic rhinitis both between and within countries (<a href="./references#CD012597-bbs2-0061" title="KatelarisCH , LeeBW , PotterPC , MasperoJF , CingiC , LopatinA , et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clinical &amp; Experimental Allergy2012;42(2):186–207. ">Katelaris 2012</a>). The review concluded that "the prevalence of allergic rhinitis is increasing and its adverse impact on the quality of life of affected individuals is increasingly recognised" (<a href="./references#CD012597-bbs2-0061" title="KatelarisCH , LeeBW , PotterPC , MasperoJF , CingiC , LopatinA , et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clinical &amp; Experimental Allergy2012;42(2):186–207. ">Katelaris 2012</a>). The increase in prevalence has been hypothesised as being due to increasing urbanisation and modification of lifestyles, which has led to reduced exposure to environmental allergens during early childhood resulting in a weaker immune system and consequent development of allergies, commonly known as the 'hygiene hypothesis' (<a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). </p> <p>There is a well‐established link between allergic rhinitis and asthma. A literature review identified that 40% of patients with allergic rhinitis had asthma (<a href="./references#CD012597-bbs2-0063" title="KimH , BouchardJ , RenziPM . The link between allergic rhinitis and asthma: a role for antileukotrienes?. Canadian Respiratory Journal2008;15(2):91‐8. ">Kim 2008</a>). The proportion of patients with asthma reporting symptoms of allergic rhinitis ranged from 30% to 80%. This connection is perhaps unsurprising as both allergic rhinitis and asthma are based on shared physiological immune responses to an identified foreign substance (allergen) (<a href="./references#CD012597-bbs2-0063" title="KimH , BouchardJ , RenziPM . The link between allergic rhinitis and asthma: a role for antileukotrienes?. Canadian Respiratory Journal2008;15(2):91‐8. ">Kim 2008</a>). </p> <p>Treatment options for allergic rhinitis include allergen avoidance, pharmacological therapy and immunotherapy. Pharmacological therapies include various classes of medications, including antihistamines, intranasal corticosteroids and anti‐leukotrienes (<a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). Nasal saline has been used as a 'natural' remedy for centuries and recent Cochrane Reviews have evaluated its efficacy as a potential treatment or adjunct to pharmacological treatment for chronic rhinosinusitis and upper respiratory tract infections (<a href="./references#CD012597-bbs2-0054" title="ChongLY , HeadK , HopkinsC , PhilpottC , GlewS , ScaddingG , et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database of Systematic Reviews2016, Issue 4. [DOI: 10.1002/14651858.CD011995.pub2] ">Chong 2016</a>; <a href="./references#CD012597-bbs2-0064" title="KingD , MitchellB , WilliamsCP , SpurlingGKP . Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD006821.pub3] ">King 2015</a>). </p> </section> <section id="CD012597-sec-0046"> <h3 class="title" id="CD012597-sec-0046">Description of the intervention</h3> <p>Saline can be deposited in the nasal cavity in various forms, including sprays, drops, nebulisers and irrigations. The volume of nasal saline from sprays and nebulisers can vary greatly. These can be very low‐volume devices (&lt; 5 mL per nostril) through to squeeze bottles and Neti pots, which are usually high‐volume devices (&gt; 60 mL). While nasal saline sprays reach the nasal cavity adequately, there is some evidence to suggest that high pressure and volume saline is more effective in penetrating the adjacent sinus cavities (<a href="./references#CD012597-bbs2-0070" title="WormaldPJ , CainT , OatesL , HawkeL , WongI . A comparative study of three methods of nasal irrigation. Laryngoscope2004;14:2224–7. ">Wormald 2004</a>). </p> <p>The saline solutions available are hypotonic (with a concentration of less than 0.9% NaCl), physiologic (with a concentration of 0.9% NaCl) and hypertonic (with a concentration of greater than 0.9% NaCl). There is some evidence in other conditions that the tonicity of the saline solution alters its efficacy (<a href="./references#CD012597-bbs2-0051" title="BerjisN , SonbolastanSM , OkhovatSH , NarimaniAA , RazmjuiJ . Normal saline versus hypertonic 3% saline: its efficacy in non‐acute rhinosinusitis. Iranian Journal of Otorhinolaryngology2011;23:23‐8. ">Berjis 2011</a>; <a href="./references#CD012597-bbs2-0067" title="RabagoD , PasicT , ZgierskaA , MundtM , BarrettB , MaberryR . The efficacy of hypertonic saline nasal irrigation for chronic sinonasal symptoms. Otolaryngology ‐ Head and Neck Surgery2005;133:3‐8. ">Rabago 2005</a>). In addition, the pH of saline solutions has been investigated and there is some evidence that solutions buffered with sodium bicarbonate (increased alkalinity) may have an impact on the nasal symptoms of people with allergic rhinitis (<a href="./references#CD012597-bbs2-0055" title="ChusakulS , WarathanasinS , SuksangpanyaN , PhannasoC , RuxrungthamS , SnidvongsK , et al. Comparison of buffered and nonbuffered nasal saline irrigations in treating allergic rhinitis. Laryngoscope2013;123:53‐6. ">Chusakul 2013</a>). </p> </section> <section id="CD012597-sec-0047"> <h3 class="title" id="CD012597-sec-0047">How the intervention might work</h3> <p>The physiological mechanisms underlying any benefit of the use of nasal saline are not fully understood but it is commonly proposed that the primary mechanism of action is mechanical (<a href="./references#CD012597-bbs2-0050" title="BarhamH , HarveyR . Nasal saline irrigation: therapeutic or homeopathic. Brazilian Journal of Otorhinolaryngology2015;81(5):457‐8. ">Barham 2015</a>). This may include clearance of mucus (saline thins mucus and helps to clear it out) (<a href="./references#CD012597-bbs2-0057" title="ElkinsMR , ByePTP . Mechanisms and applications of hypertonic saline. Journal of the Royal Society of Medicine2011;104:S2‐5. ">Elkins 2011</a>), and removal of airborne allergens and inflammation mediators such as histamine (<a href="./references#CD012597-bbs2-0058" title="GeorgitisJW . Nasal hyperthermia and simple irrigation for perennial rhinitis. Changes in inflammatory mediators. Chest1994;106(5):1487‐92. ">Georgitis 1994</a>). There is some evidence to suggest that at some concentrations nasal saline may improve ciliary beat function (<a href="./references#CD012597-bbs2-0052" title="BonnometA , LuczkaE , CorauxC , deGaboryL . Non‐diluted seawater enhances nasal ciliary beat frequency and wound repair speed compared to diluted seawater and normal saline. International Forum of Allergy &amp; Rhinology2016;6(10):1062‐8. ">Bonnomet 2016</a>) and mucociliary function (<a href="./references#CD012597-bbs2-0060" title="HermelingmeierKE , WeberRK , HellmichM , HeubachCP , MosgesR . Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta‐analysis. American Journal of Rhinology &amp; Allergy2012;26(5):e119‐25. [DOI: 10.2500/ajra.2012.26.3787] ">Hermelingmeier 2012</a>). Adverse effects of nasal saline irrigation are thought to be rare and generally mild but may include ear fullness, stinging of the nasal mucosa and epistaxis (nosebleed) (<a href="./references#CD012597-bbs2-0062" title="KhianeyR , OppenheimerJ . Is nasal saline irrigation all it is cracked up to be?. Annals of Allergy, Asthma &amp; Immunology2012;109:20‐8. ">Khianey 2012</a>). </p> </section> <section id="CD012597-sec-0048"> <h3 class="title" id="CD012597-sec-0048">Why it is important to do this review</h3> <p>Allergic rhinitis is a highly prevalent condition in adults and children, with a large impact on patients and high healthcare costs: both direct, from the cost of repeat healthcare visits and of chronic medical therapy, and indirect, via absenteeism and lost productivity (<a href="./references#CD012597-bbs2-0069" title="SchoenwetterWF , DupclayLJr , AppajosyulaS , BottemanMF , PashosCL . Economic impact and quality‐of‐life burden of allergic rhinitis. Current Medical Research and Opinion2004;20(3):305‐17. ">Schoenwetter 2004</a>). </p> <p>Previous Cochrane Reviews have demonstrated some possible benefit of saline in adults with chronic rhinosinusitis (<a href="./references#CD012597-bbs2-0054" title="ChongLY , HeadK , HopkinsC , PhilpottC , GlewS , ScaddingG , et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database of Systematic Reviews2016, Issue 4. [DOI: 10.1002/14651858.CD011995.pub2] ">Chong 2016</a>) and in people with upper respiratory tract infections (<a href="./references#CD012597-bbs2-0064" title="KingD , MitchellB , WilliamsCP , SpurlingGKP . Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD006821.pub3] ">King 2015</a>). The two most recent systematic reviews identified on the use of nasal saline in allergic rhinitis had latest search dates of 2010 (<a href="./references#CD012597-bbs2-0060" title="HermelingmeierKE , WeberRK , HellmichM , HeubachCP , MosgesR . Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta‐analysis. American Journal of Rhinology &amp; Allergy2012;26(5):e119‐25. [DOI: 10.2500/ajra.2012.26.3787] ">Hermelingmeier 2012</a>) and December 2011 (<a href="./references#CD012597-bbs2-0062" title="KhianeyR , OppenheimerJ . Is nasal saline irrigation all it is cracked up to be?. Annals of Allergy, Asthma &amp; Immunology2012;109:20‐8. ">Khianey 2012</a>). <a href="./references#CD012597-bbs2-0062" title="KhianeyR , OppenheimerJ . Is nasal saline irrigation all it is cracked up to be?. Annals of Allergy, Asthma &amp; Immunology2012;109:20‐8. ">Khianey 2012</a> limited their inclusion criteria to studies published in English and also included studies in populations with a range of different sinonasal conditions including upper respiratory tract infection and chronic rhinosinusitis. <a href="./references#CD012597-bbs2-0060" title="HermelingmeierKE , WeberRK , HellmichM , HeubachCP , MosgesR . Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta‐analysis. American Journal of Rhinology &amp; Allergy2012;26(5):e119‐25. [DOI: 10.2500/ajra.2012.26.3787] ">Hermelingmeier 2012</a> specified the population as people with seasonal or perennial allergic rhinitis. This review looked at prospective trials (including before and after studies) and only included studies published in English or German. Both reviews identified potential benefits for people in terms of symptom improvement and found that saline irrigation was well tolerated, but both reviews highlighted the need for further research in this area in order for definitive conclusions to be drawn. This review will include recently published studies and we will apply no restriction with regard to language of publication. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012597-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012597-sec-0049">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012597-sec-0208">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012597-sec-0049"></div> <p>To evaluate the effects of nasal saline irrigation in people with allergic rhinitis.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012597-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012597-sec-0050">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012597-sec-0209">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012597-sec-0050"></div> <section id="CD012597-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012597-sec-0052"> <h4 class="title">Types of studies</h4> <p>We <b>included</b> studies with the following design characteristics: </p> <p> <ul id="CD012597-list-0001"> <li> <p>randomised controlled trials, including cluster‐randomised trials and quasi‐randomised trials, and cross‐over trials if the data from the first phase were available; </p> </li> <li> <p>participants were followed up for at least two weeks.</p> </li> </ul> </p> <p>We <b>excluded</b> studies with the following design characteristics: </p> <p> <ul id="CD012597-list-0002"> <li> <p>randomised participants by side of nose (within‐patient controlled) because it is difficult to ensure that the effects of any of the interventions considered can be localised; or </p> </li> <li> <p>perioperative studies, where the sole purpose of the study was to investigate the effect of nasal saline irrigation on surgical outcomes. </p> </li> </ul> </p> </section> <section id="CD012597-sec-0053"> <h4 class="title">Types of participants</h4> <p>Patients (adults and children) with clinical symptoms characteristic of allergic rhinitis with a positive radioallergosorbent test (RAST) or skin prick test (SPT). </p> <p>We <b>excluded</b> studies that included a majority (more than 50%) of participants with: </p> <p> <ul id="CD012597-list-0003"> <li> <p>non‐allergic rhinitis;</p> </li> <li> <p>chronic rhinosinusitis;</p> </li> <li> <p>acute sinusitis;</p> </li> <li> <p>cystic fibrosis;</p> </li> <li> <p>immunotherapy started within the prior year;</p> </li> <li> <p>any alteration of allergic rhinitis‐specific pharmacotherapy (antihistamines, intranasal corticosteroids, anti‐leukotrienes) during the trial; </p> </li> <li> <p>aspirin‐exacerbated respiratory disease;</p> </li> <li> <p>surgery for turbinate reduction within three months prior to study.</p> </li> </ul> </p> <p>Had we found a study that included a mixed group of participants, we would have excluded it if more than 50% of the participants met the 'excluded' population criteria above, unless the study reported the results for the different populations separately. Similarly, if there had been a study where more than 50% of the people had allergic rhinitis we would have included the study but, where possible, we would only have used the results for the population with allergic rhinitis providing the randomisation had been stratified. </p> </section> <section id="CD012597-sec-0054"> <h4 class="title">Types of interventions</h4> <p>The use of saline, as an active treatment, delivered to the nose by any means (douche, irrigation, pulsed, spray or nebuliser). </p> <p><b>Tonicity:</b> we included all concentrations of saline. 'Hypotonic' was defined as a concentration of less than 0.9% NaCl, 'physiologic' as 0.9% NaCl and 'hypertonic' as greater than 0.9% NaCl. </p> <p><b>Volume:</b> we included all volumes of saline treatments. 'Very low‐volume' related to misting sprays or other delivery methods where the volume of application is likely to be less than 5 mL per nostril per application. 'Low‐volume' was defined as between 5 mL and 59 mL per nostril per application. 'High‐volume' was defined as a volume of 60 mL or greater per nostril per application. </p> <p>We included studies investigating 'buffered' saline solutions where the aim was to adjust the pH of the solution. We excluded studies that used formulations of saline solution that contained other additives, such as xylitol, antibacterials and surfactants. We also excluded studies using other formulations, such as lactated Ringer's solution. </p> <p>There was no minimum duration of treatment.</p> <section id="CD012597-sec-0055"> <h5 class="title">Comparisons</h5> <p>The main comparison pairs were:</p> <p> <ul id="CD012597-list-0004"> <li> <p>nasal saline <i>versus</i> no saline irrigation; </p> </li> <li> <p>nasal saline plus pharmacological treatment <i>versus</i> pharmacological treatment alone. </p> </li> </ul> </p> <p>Other possible comparison pairs included:</p> <p> <ul id="CD012597-list-0005"> <li> <p>nasal saline <i>versus</i> pharmacological treatment. </p> </li> </ul> </p> <p>The term 'pharmacological treatment' refers to commonly accepted treatments for allergic rhinitis such as oral antihistamines and intranasal corticosteroids, as recommended by internationally accepted treatment guidelines, such as the ARIA guidelines (<a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). </p> </section> </section> <section id="CD012597-sec-0056"> <h4 class="title">Types of outcome measures</h4> <p>We analysed the following outcomes in the review, but we did not use them as a basis for including or excluding studies. </p> <section id="CD012597-sec-0057"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD012597-list-0006"> <li> <p>Disease severity, as measured by patient‐reported symptom score (such as the Total Nasal Symptom Score (TNSS) questionnaire and visual analogue scales (VAS)). </p> </li> <li> <p>Significant local adverse effects: epistaxis.</p> </li> </ul> </p> </section> <section id="CD012597-sec-0058"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD012597-list-0007"> <li> <p>Disease‐specific health‐related quality of life, using validated disease‐specific health‐related quality of life scores, such as the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) and Rhinitis Symptom Utility Index (RSUI). </p> </li> <li> <p>Individual symptom scores for the following symptoms:</p> <ul id="CD012597-list-0008"> <li> <p>anterior rhinorrhoea (runny nose): where a study reports 'rhinorrhoea' as the outcome, in the absence of a definition within the paper we assumed that this measured anterior rhinorrhoea. Where the authors reported a combined outcome for anterior and posterior rhinorrhoea and we were not able to obtain individual results, we recorded this as a combined 'anterior and posterior rhinorrhoea' category; </p> </li> <li> <p>posterior rhinorrhoea (post‐nasal drip);</p> </li> <li> <p>nasal blockage or congestion or obstruction;</p> </li> <li> <p>nasal itching;</p> </li> <li> <p>sneezing.</p> </li> </ul> </li> <li> <p>Generic health‐related quality of life, using validated generic quality of life scores, such as the SF‐36, EQ‐5D and other well‐validated instruments. </p> </li> <li> <p>Any other local adverse effects: local irritation, discomfort.</p> </li> <li> <p>Aural symptoms: ear pain, pressure or feeling of fullness.</p> </li> <li> <p>Endoscopic score (e.g. Lund‐Mackay/Lund‐Kennedy).</p> </li> </ul> </p> <p>As both short‐term and long‐term effects are important we evaluated efficacy outcomes at the following time points: </p> <p> <ul id="CD012597-list-0009"> <li> <p>up to four weeks from the start of treatment (particularly relevant for intermittent allergic rhinitis); </p> </li> <li> <p>from four weeks to six months;</p> </li> <li> <p>from six months to 12 months; and</p> </li> <li> <p>at more than 12 months (particularly relevant for persistent allergic rhinitis).</p> </li> </ul> </p> <p>Where a study reported data for an outcome at more than one time point, we included the data for the longest of each of the four time points above. For example, if a study reported outcomes at one week, three weeks and 12 weeks from the start of treatment, we used the three‐week results (for the up to four weeks time point) and the 12‐week results (for the four weeks to six months time point). We paid attention during the analysis to the prevention of 'double counting' of studies when presenting summary results. </p> <p>For adverse effects, we analysed data from the longest time periods available.</p> </section> </section> </section> <section id="CD012597-sec-0059"> <h3 class="title">Search methods for identification of studies</h3> <p>The Cochrane ENT Information Specialist conducted systematic searches for randomised controlled trials and controlled clinical trials. There were no language, publication year or publication status restrictions. The date of the search was 23 November 2017. </p> <section id="CD012597-sec-0060"> <h4 class="title">Electronic searches</h4> <p>The Information Specialist searched:</p> <p> <ul id="CD012597-list-0010"> <li> <p>the Cochrane ENT Trials Register (searched via CRS Web 23 November 2017);</p> </li> <li> <p>the Cochrane Register of Controlled Trials (CENTRAL) (searched via CRS Web 23 November 2017); </p> </li> <li> <p>Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) (1946 to 23 November 2017); </p> </li> <li> <p>Ovid EMBASE (1974 to 23 November 2017);</p> </li> <li> <p>Ovid CAB Abstracts (1910 to 23 November 2017);</p> </li> <li> <p>EBSCO CINAHL (1982 to 23 November 2017);</p> </li> <li> <p>Ovid AMED (1985 to 23 November 2017);</p> </li> <li> <p>LILACS, <a href="http://lilacs.bvsalud.org" target="_blank">lilacs.bvsalud.org</a> (searched 23 November 2017); </p> </li> <li> <p>KoreaMed (searched via Google Scholar 23 November 2017);</p> </li> <li> <p>IndMed, <a href="http://www.indmed.nic.in" target="_blank">www.indmed.nic.in</a> (searched 23 November 2017); </p> </li> <li> <p>PakMediNet, <a href="http://www.pakmedinet.com" target="_blank">www.pakmedinet.com</a> (searched 23 November 2017); </p> </li> <li> <p>Web of Knowledge, Web of Science (1945 to 23 November 2017);</p> </li> <li> <p>ClinicalTrials.gov (searched via the Cochrane Register of Studies 23 November 2017);</p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), <a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a> (searched 23 November 2017). </p> </li> </ul> </p> <p>The Information Specialist modelled subject strategies for databases on the search strategy designed for CENTRAL. Where appropriate, they were combined with subject strategy adaptations of the highly sensitive search strategy designed by Cochrane for identifying randomised controlled trials and controlled clinical trials (as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Version 5.1.0, Box 6.4.b. (<a href="./references#CD012597-bbs2-0059" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Handbook 2011</a>). Search strategies for major databases including CENTRAL are provided in <a href="./appendices#CD012597-sec-0191">Appendix 1</a>. </p> </section> <section id="CD012597-sec-0061"> <h4 class="title">Searching other resources</h4> <p>We scanned the reference lists of identified publications for additional trials and contacted trial authors where necessary. In addition, the Information Specialist searched Ovid MEDLINE and the<i>Cochrane Library</i> to retrieve existing systematic reviews relevant to this systematic review, so that we could scan their reference lists for additional trials. The Information Specialist also ran non‐systematic searches of Google Scholar to retrieve grey literature and other sources of potential trials. </p> </section> </section> <section id="CD012597-sec-0062"> <h3 class="title" id="CD012597-sec-0062">Data collection and analysis</h3> <section id="CD012597-sec-0063"> <h4 class="title">Selection of studies</h4> <p>At least two review authors (KH, SG, KS, GS) independently screened all titles and abstracts of the studies obtained from the database searches to identify potentially relevant studies. Two review authors (KH, CP) evaluated the full text of each potentially relevant study to determine whether it met the inclusion and exclusion criteria for this review. </p> <p>We resolved any differences by discussion and consensus, with the involvement of a third author for clinical and/methodological input had it been necessary. </p> </section> <section id="CD012597-sec-0064"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (KH and KS) independently extracted data from each study using a standardised data collection form (see <a href="./appendices#CD012597-sec-0192">Appendix 2</a>). Whenever a study had more than one publication, we retrieved all publications to ensure complete extraction of data. Where there were discrepancies in the data extracted by different review authors, we checked these against the original reports and we resolved differences by discussion and consensus, with the involvement of a third author or a methodologist where necessary. We contacted the original study authors for clarification or for missing data whenever required. If we found differences between publications of a study, we contacted the original authors for clarification. We used data from the main paper(s) where no further information was found. </p> <p>We included key characteristics of the studies, such as study design, setting, sample size, population and how outcomes were defined or collected in the studies. In addition, we also collected baseline information on prognostic factors or effect modifiers. For this review, this included: </p> <p> <ul id="CD012597-list-0011"> <li> <p>age of participants;</p> </li> <li> <p>intermittent or persistent allergic rhinitis;</p> </li> <li> <p>type of allergic trigger (e.g. mites, pollens, animals, etc.);</p> </li> <li> <p>severity of allergic rhinitis ('mild' or 'moderate/severe' as defined in <a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). </p> </li> </ul> </p> <p>For the outcomes of interest to the review, we extracted the findings of the studies on an available case analysis basis; i.e. we included data from all participants available at the time points based on the treatment randomised whenever possible, irrespective of compliance or whether participants had received the treatment as planned. </p> <p>In addition to extracting prespecified information about study characteristics and aspects of methodology relevant to risk of bias, we extracted the following summary statistics for each trial and each outcome: </p> <p> <ul id="CD012597-list-0012"> <li> <p>For continuous data: the mean values, standard deviations and number of participants for each treatment group. Where endpoint data were not available, we extracted the values for change from baseline. We analysed data from measurement scales such as RQLQ as continuous data. </p> </li> <li> <p>For binary data: the numbers of participants experiencing an effect and the number of participants assessed at the time point. </p> </li> <li> <p>For ordinal scale data: if the data appeared to be approximately normally distributed or if the analysis that the investigators performed suggested parametric tests were appropriate, then we treated the outcome measures as continuous data. If data had been available, we would have converted into binary data. </p> </li> </ul> </p> <p>We prespecified the time points of interest for the outcomes in this review (<a href="#CD012597-sec-0056">Types of outcome measures</a>). While studies had reported data at multiple time points, we only extracted the longest available data within the time points of interest. For example, if a study reported data at one, two and four weeks, we only extracted and analysed the data for the four‐week follow‐up. </p> <section id="CD012597-sec-0065"> <h5 class="title">Extracting data from figures</h5> <p>Where values for primary or secondary outcomes were shown as figures within the paper we contacted the study authors to try to obtain the raw values. When the raw values were not provided, we extracted information from the graphs using an online data extraction tool (<a href="http://arohatgi.info/WebPlotDigitizer/app/" target="_blank">http://arohatgi.info/WebPlotDigitizer/app/</a>), using the best quality version of the relevant figures available. </p> </section> </section> <section id="CD012597-sec-0066"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>KH and KS undertook assessment of the risk of bias of the included studies independently, with the following taken into consideration, as guided by the<i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012597-bbs2-0059" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Handbook 2011</a>): </p> <p> <ul id="CD012597-list-0013"> <li> <p>sequence generation;</p> </li> <li> <p>allocation concealment;</p> </li> <li> <p>blinding;</p> </li> <li> <p>incomplete outcome data;</p> </li> <li> <p>selective outcome reporting; and</p> </li> <li> <p>other sources of bias.</p> </li> </ul> </p> <p>We used the Cochrane 'Risk of bias' tool in RevMan 5.3 (<a href="./references#CD012597-bbs2-0068" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), which involves describing each of these domains as reported in the trial and then assigning a judgement about the adequacy of each entry: 'low', 'high' or 'unclear' risk of bias. </p> </section> <section id="CD012597-sec-0067"> <h4 class="title">Measures of treatment effect</h4> <p>We summarised the effects of dichotomous outcomes (e.g. proportion of participants with symptom resolution) as risk ratios (RR) with 95% confidence intervals (CIs). For the key outcomes that were presented in the 'Summary of findings' tables, we also expressed the results as absolute numbers based on the pooled results and compared to the assumed risk. We would have calculated the number needed to treat to benefit (NNTB) using the pooled results had it made sense to do so. The assumed baseline risk would typically be either (a) the median of the risks of the control groups in the included studies, this being used to represent a 'medium‐risk population' or, alternatively, (b) the average risk of the control groups in the included studies used to represent the 'study population' (<a href="./references#CD012597-bbs2-0059" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Handbook 2011</a>). Had a large number of studies been available, and where appropriate, we would have also presented additional data based on the assumed baseline risk in (c) a low‐risk population and (d) a high‐risk population. </p> <p>For continuous outcomes, we expressed treatment effects as a mean difference (MD) with standard deviation (SD). When different scales were used to measure the same outcome we used the standardised mean difference (SMD), and we provided a clinical interpretation of the SMD values. </p> </section> <section id="CD012597-sec-0068"> <h4 class="title">Unit of analysis issues</h4> <p>This review did not use data from phase II of cross‐over studies or from studies where the participant was not the unit of randomisation, i.e. studies where the side of the nose (right versus left) was randomised. </p> <p>If we had found cluster‐randomised trials, we would have analysed these according to the methods in section 16.3.3 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012597-bbs2-0059" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Handbook 2011</a>). </p> </section> <section id="CD012597-sec-0069"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors via email whenever the outcome of interest was not reported if the methods of the study suggest that the outcome had been measured. We did the same if not all data required for meta‐analysis were reported, unless the missing data were standard deviations. When standard deviation data were not available we approximated these using the standard estimation methods from P values, standard errors or 95% CIs if these were reported, as detailed in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012597-bbs2-0059" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Handbook 2011</a>). Had it been impossible to estimate these, we would have contacted the study authors. </p> <p>Apart from imputations for missing standard deviations, we did not conduct any other imputations. We extracted and analysed data for all outcomes using the available case analysis method. </p> </section> <section id="CD012597-sec-0070"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity (which may be present even in the absence of statistical heterogeneity) by examining the included trials for potential differences between studies in the types of participants recruited (including age of participants), interventions or controls used and the outcomes measured. </p> <p>We assessed statistical heterogeneity by visually inspecting the forest plots and by considering the Chi² test (with a significance level set at P &lt; 0.10) and the I² statistic, which calculates the percentage of variability that is due to heterogeneity rather than chance, with I² values over 50% suggesting substantial heterogeneity (<a href="./references#CD012597-bbs2-0059" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Handbook 2011</a>). </p> </section> <section id="CD012597-sec-0071"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed reporting bias as between‐study publication bias and within‐study outcome reporting bias. </p> <section id="CD012597-sec-0072"> <h5 class="title">Outcome reporting bias (within‐study reporting bias)</h5> <p>We assessed within‐study reporting bias by comparing the outcomes reported in the published report against the study protocol, whenever this could be obtained. If the protocol was not available, we compared the outcomes reported to those listed in the methods section. If results are mentioned but not reported adequately in a way that allows analysis (e.g. the report only mentions whether the results were statistically significant or not), bias in a meta‐analysis is likely to occur. We tried to find further information from the study authors. If no further information was obtained, we noted this as being a 'high' risk of bias. Where there was insufficient information to judge the risk of bias we noted this as an 'unclear' risk of bias (<a href="./references#CD012597-bbs2-0059" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Handbook 2011</a>). </p> </section> <section id="CD012597-sec-0073"> <h5 class="title">Publication bias (between‐study reporting bias)</h5> <p>We had planned to create funnel plots if sufficient studies (more than 10) were available for an outcome. If we had observed asymmetry of the funnel plot, we had planned to conduct more formal investigation using the methods proposed by <a href="./references#CD012597-bbs2-0056" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical research ed.)1997;315(7109):629‐34. [PUBMED: 9310563] ">Egger 1997</a>. </p> </section> </section> <section id="CD012597-sec-0074"> <h4 class="title">Data synthesis</h4> <p>We conducted all meta‐analyses using Review Manager 5.3 (<a href="./references#CD012597-bbs2-0068" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). For dichotomous data, we analysed treatment differences as a risk ratio (RR) calculated using the Mantel‐Haenszel methods. We would have analysed time‐to‐event data using the generic inverse variance method. </p> <p>For continuous outcomes, if all the data were from the same scale, we pooled mean values obtained at follow‐up with the change in outcomes (i.e. difference between pre‐ versus post‐treatment values) and reported this as a MD. However, if the SMD had to be used as an effect measure, we would not have pooled change and endpoint data. </p> <p>When statistical heterogeneity is low, random‐effects versus fixed‐effect methods yield trivial differences in treatment effects. However, when statistical heterogeneity is high, the random‐effects method provides a more conservative estimate of the difference. </p> </section> <section id="CD012597-sec-0075"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where data were available, we conducted some subgroup analyses regardless of whether statistical heterogeneity was observed, as these were widely suspected to be potential effect modifiers. For this review, this included the following. </p> <p> <ul id="CD012597-list-0014"> <li> <p>Volume of saline delivery (e.g. 'very low', 'low' and 'high' volume). There is evidence of a difference in effectiveness between high‐ and low‐volume saline irrigation in people with chronic sinonasal symptoms (<a href="./references#CD012597-bbs2-0066" title="PynnonenMA , MukerjiSS , KimHM , AdamsME , TerrellJE . Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Archives of Otolaryngology‐‐Head &amp; Neck Surgery2007;133(11):1115‐20. ">Pynnonen 2007</a>). </p> </li> <li> <p>Tonicity of saline solution (hypertonic, isotonic and hypotonic solutions). There is some evidence in other conditions that tonicity may have an effect on the efficacy of nasal saline (<a href="./references#CD012597-bbs2-0051" title="BerjisN , SonbolastanSM , OkhovatSH , NarimaniAA , RazmjuiJ . Normal saline versus hypertonic 3% saline: its efficacy in non‐acute rhinosinusitis. Iranian Journal of Otorhinolaryngology2011;23:23‐8. ">Berjis 2011</a>; <a href="./references#CD012597-bbs2-0067" title="RabagoD , PasicT , ZgierskaA , MundtM , BarrettB , MaberryR . The efficacy of hypertonic saline nasal irrigation for chronic sinonasal symptoms. Otolaryngology ‐ Head and Neck Surgery2005;133:3‐8. ">Rabago 2005</a>). </p> </li> <li> <p>Alkalinity of saline solution. There is evidence that increased alkalinity of the saline solution improves some nasal symptoms (<a href="./references#CD012597-bbs2-0055" title="ChusakulS , WarathanasinS , SuksangpanyaN , PhannasoC , RuxrungthamS , SnidvongsK , et al. Comparison of buffered and nonbuffered nasal saline irrigations in treating allergic rhinitis. Laryngoscope2013;123:53‐6. ">Chusakul 2013</a>). </p> </li> <li> <p>Participant age (children, adults or mixed population). There may be differences in physiology that are unknown and compliance and volumes may well be quite different in the paediatric population compared to adults. </p> </li> </ul> </p> <p>We initially planned to present the main analyses of this review according to the volume of saline delivery, however we changed this to present the initial analyses subgrouped by age during the process of the review (<a href="#CD012597-sec-0198">Differences between protocol and review</a>). We presented all other subgroup analysis results in tables and as forest plots. </p> <p>In addition to the subgroups above, we had planned to conduct the following subgroup analyses in the presence of statistical heterogeneity: </p> <p> <ul id="CD012597-list-0015"> <li> <p>method of delivery (e.g. nebuliser, spray, irrigation);</p> </li> <li> <p>duration of treatment;</p> </li> <li> <p>frequency of allergic rhinitis symptoms (e.g. intermittent or persistent as defined by <a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>), where an older study using the 'seasonal' and 'perennial' classification was used, we would have interpreted 'seasonal' as 'intermittent' and 'perennial' as 'persistent' allergic rhinitis unless there was specific information in the paper that would make this inappropriate; </p> </li> <li> <p>severity of symptoms (mild, moderate/severe as defined by <a href="./references#CD012597-bbs2-0049" title="BousquetJ , KhaltaevN , CruzAA ,  DenburgJ ,  FokkensWJ ,  TogiasA , et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy2008;63:8‐160. ">ARIA 2008</a>). </p> </li> </ul> </p> <p>When studies had a mixed group of participants, we had planned to analyse the study as one of the subgroups (rather than as a mixed group) if more than 80% of the participants belong to one category. For example, if 81% of participants were over 18, we would have analysed the study as though the participants were adults. </p> </section> <section id="CD012597-sec-0076"> <h4 class="title">Sensitivity analysis</h4> <p>We had planned to carry out sensitivity analyses to determine whether the findings were robust to the decisions made in the course of identifying, screening and analysing the trials. We had planned to conduct sensitivity analysis for the following factors, whenever possible: </p> <p> <ul id="CD012597-list-0016"> <li> <p>impact of model chosen: fixed‐effect versus random‐effects model;</p> </li> <li> <p>risk of bias of included studies: evaluating the impact of missing data on the results of the studies due to participant attrition, to determine whether the missing outcome data for the participants in the trial could have influenced the results of the review; </p> </li> <li> <p>how outcomes were measured: we planned to investigate the impact of including data where the validity of the measurement instrument used was unclear. </p> </li> </ul> </p> <p>If any of these investigations had found a difference in the size of the effect or heterogeneity, we would have mentioned this in the <a href="#CD012597-sec-0125">Effects of interventions</a> section. </p> <section id="CD012597-sec-0077"> <h5 class="title">GRADE and 'Summary of findings' table</h5> <p>Using the GRADE approach, at least two review authors (KH, KS) independently rated the overall quality of evidence using the GDT tool (<a href="http://www.guidelinedevelopment.org/" target="_blank">http://www.guidelinedevelopment.org/</a>) for the main comparison pairs listed in the <a href="#CD012597-sec-0054">Types of interventions</a> section. The quality of evidence reflects the extent to which we are confident that an estimate of effect is correct and we applied this in the interpretation of results. There are four possible ratings: high, moderate, low and very low. A rating of high quality of evidence implies that we are confident in our estimate of effect and that further research is very unlikely to change our confidence in the estimate of effect. A rating of very low quality implies that any estimate of effect obtained is very uncertain. </p> <p>The GRADE approach rates evidence from RCTs that do not have serious limitations as high quality. However, several factors can lead to the downgrading of the evidence to moderate, low or very low. The degree of downgrading is determined by the seriousness of these factors: </p> <p> <ul id="CD012597-list-0017"> <li> <p>study limitations (risk of bias);</p> </li> <li> <p>inconsistency;</p> </li> <li> <p>indirectness of evidence;</p> </li> <li> <p>imprecision; and</p> </li> <li> <p>publication bias.</p> </li> </ul> </p> <p>We included a 'Summary of findings' table, constructed according to the recommendations described in Chapter 10 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012597-bbs2-0059" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Handbook 2011</a>). We included the following outcomes in the 'Summary of findings' table: patient‐reported disease severity score, individual symptom scores, significant adverse effects (epistaxis), disease‐specific health‐related quality of life and other adverse effects (local irritation/discomfort). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012597-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012597-sec-0078"></div> <section id="CD012597-sec-0079"> <h3 class="title">Description of studies</h3> <section id="CD012597-sec-0080"> <h4 class="title">Results of the search</h4> <p>The searches retrieved a total of 1402 references after removal of duplicates. We identified three additional references from other sources. We screened the titles and abstracts and subsequently removed 1319 references. We assessed 86 full texts for eligibility of which we excluded 66 references; we excluded 31 of these references (29 studies) with reasons recorded in the review (<a href="#CD012597-sec-0105">Excluded studies</a>). </p> <p>We included 16 references (14 studies). We did not identify any ongoing studies. There are four references awaiting assessment (see below). </p> <p>A flow chart of study retrieval and selection is provided in <a href="#CD012597-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD012597-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012597-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012597-sec-0081"> <h4 class="title">Included studies</h4> <p>All of the 14 studies (16 references) included were parallel‐group randomised controlled trials (RCTs). Two studies were described as 'single‐blinded' whereas the remaining 12 were non‐blinded studies. All except one were single‐centre studies. Seven studies included two treatment arms and seven included three treatment arms. The range of follow‐up varied from 7 days to 12 weeks. Full details can be found in the <a href="./references#CD012597-sec-0200" title="">Characteristics of included studies</a> table. </p> <section id="CD012597-sec-0082"> <h5 class="title">Setting</h5> <p>The studies came from five countries: six were conducted in Italy (<a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>; <a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a>), five in China (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>; <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>), and one in each in Thailand (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>), Turkey (<a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>) and the USA (<a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>). </p> <p>The setting of the studies is not clearly described within the papers. We assumed that most studies recruited their participants from secondary care but one study was conducted in family practices (primary care) (<a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>), and four other studies were very unclear about the setting (<a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>). </p> </section> <section id="CD012597-sec-0083"> <h5 class="title">Population</h5> <p>A total of 747 participants were involved in the studies. The sample size of the studies ranged from 14 to 160 participants. Only one study included more than 100 participants and the median study size was 46 participants. </p> <section id="CD012597-sec-0084"> <h6 class="title">Age</h6> <p>Seven studies included only children (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>; <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>). Six of these reported the mean age, which ranged from 6 to 11 years. The median of the mean ages was 9.4 years. Only one study included children of less than five years (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>). </p> <p>Seven studies only included adults (<a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>; <a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>; <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>; <a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>). Five studies reported the mean ages of the participants and these ranged from 24 to 47 years. The median of the mean ages was 33.9 years. </p> </section> <section id="CD012597-sec-0085"> <h6 class="title">Sex</h6> <p>Thirteen of the 14 included studies included both males and females. The proportion of males in the studies ranged from 39% to 62%. One study included only pregnant women (<a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>). </p> </section> <section id="CD012597-sec-0086"> <h6 class="title">Diagnosis</h6> <p>Eleven studies diagnosed participants with allergic rhinitis and two specified that included participants had allergic rhinoconjunctivitis (<a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>). <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a> only included participants with allergic rhinitis and chronic cough (lasting for eight weeks or more). </p> <p>Five studies stated (or it could be interpreted) that they included participants with persistent allergic rhinitis, and six included participants with seasonal allergic rhinitis. Further details of the type and severity of allergic rhinitis, and the allergen type, for participants included in the studies are shown in <a href="#CD012597-tbl-0003">Table 1</a>. </p> <div class="table" id="CD012597-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study characteristics</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comparison</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intermittent/ persistent</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Allergen</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tonicity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Volume<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Administration methods</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adjuvant</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment duration</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a> (Thailand) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mild/moderate</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated (persistent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>House dust mite, cockroach, cat, dog, grass, moulds</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Normal'/isotonic saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 mL</p> <p>(high)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day using Hashi® Nasal Rinser</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If needed: cetirizine and pseudoephedrine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate/severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>House dust mites and mould</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (sea water)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 6 sprays, 2 times per day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 μg fluticasone propionate nasal spray daily</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a> (USA) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>21</p> <p>Adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Seasonal</p> <p>(intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pollen and <i>Alternaria</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Hypertonic Dead Sea saline spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sprays, 3 times per day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aqueous triamcinolone spray (110 μg into each nostril once daily)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2. Normal saline spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sprays, 3 times per day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aqueous triamcinolone spray (110 μg into each nostril once daily)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> <p>Adults</p> <p>(allergic rhinoconjunctivitis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grass pollen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (% not given)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15 mL</p> <p>(very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, using a nasal aerosol spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Parietaria</i> pollen </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (3%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mL</p> <p>(very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day, using disposable syringe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> <p>Children</p> <p>(allergic rhinoconjunctivitis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grass pollen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (3%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15 mL</p> <p>(very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day, spray from bottle fitted with an atomiser</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>Adults</p> <p>(pregnant women)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Parietaria</i> pollen </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (3%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 mL</p> <p>(low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day, using disposable syringe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>26</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate/severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>House dust mites and mould</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>'Normal' (0.9%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>500 mL</p> <p>(high)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day using positive‐pressure nasal irrigation applicator</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256 μg budesonide nasal spray daily</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day using positive‐pressure nasal irrigation applicator</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> <p>Adults (allergic rhinitis with chronic cough)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>House dust mites</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Normal' (0.9%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 mL</p> <p>(high)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal pharyngeal irrigation (pumping saline solution from a solution bag hung on a drip stand overhead into each nostril and allowing it to run out of the mouth) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>220</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Grass pollen including orchard and rye grass</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Hypertonic (2.7%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 mL</p> <p>(low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, irrigation using bulb syringe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2. 'Normal' (0.9%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 mL</p> <p>(low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, irrigation using bulb syringe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>30</p> <p>Adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate/severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mugwort pollen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated: 1 'puff' (very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2 times per day, using a nasal aerosol spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Budesonide, 128 µg per nostril per day</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14</p> <p>Adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>House dust mites and/or <i>Parietaria</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (% not given)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cetirizine, orally, 10 mg/day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antihistamines alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61</p> <p>Adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>'Normal' (% not given)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>75 mL</p> <p>(high)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, no method given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Budesonide, intranasal steroid spray, 64 µg/spray, 1 spray twice day (in morning and at night) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, no method given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a> (Turkey) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mild, moderate and severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent and seasonal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> <p>"2 puffs"</p> <p>(very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 'puffs' per nostril per day, using a nasal aerosol spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mometasone furoate (2 puffs in each nostril per day)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>Volume reported as per nostril per application. The volume categories were defined as: VERY LOW: less than 5 ml per nostril per application; LOW: between 5 ml to 59 ml per nostril per application; HIGH: ≥ 60 ml per nostril per application. </p> </div> </div> </section> </section> <section id="CD012597-sec-0087"> <h5 class="title">Interventions</h5> <section id="CD012597-sec-0088"> <h6 class="title">Saline solution</h6> <p>Details of the tonicity, volume and method of administration of the saline solution are provided in <a href="#CD012597-tbl-0003">Table 1</a>. </p> <p>In summary:</p> <p> <ul id="CD012597-list-0018"> <li> <p>Eight studies used hypertonic saline and five studies used isotonic ('normal') saline. Three studies did not provide any information about tonicity. </p> </li> <li> <p>Five studies used very low‐volume saline, two used low‐volume saline and four used high‐volume saline. Three studies did not provide information on the volume. </p> </li> <li> <p>Five studies allowed oral antihistamines to be used as rescue medication when needed (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>). <a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a> stated that pseudoephedrine was also prescribed as rescue medication. </p> </li> <li> <p>The duration of treatment ranged from seven days to three months.</p> </li> </ul> </p> </section> </section> <section id="CD012597-sec-0089"> <h5 class="title">Comparisons</h5> <section id="CD012597-sec-0090"> <h6 class="title">Saline <i>versus</i> no saline treatment </h6> <p>Seven studies compared nasal saline irrigation with no saline treatment (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>; <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>). <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a> was a three‐arm study that compared two different types of nasal saline (hypertonic and isotonic saline) with no saline treatment. </p> </section> <section id="CD012597-sec-0091"> <h6 class="title">Saline plus pharmacological treatment <i>versus</i> pharmacological treatment alone </h6> <p>Three studies included arms where both nasal saline irrigation and <b>intranasal corticosteroids</b> were given. The intranasal steroids given were budesonide nasal spray in <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a> (256 μg/day for four weeks, 128 μg/day for four weeks and 64 μg/day for four weeks) and <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> (128 µg/day for three months); and fluticasone proportionate nasal spray in <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> (200 μg/day for four weeks, 100 μg/day for four weeks and 50 μg/day for four weeks). It was not explicitly stated in any of the studies in which order the saline and steroid treatments were given. </p> <p>One study used an <b>oral antihistamine</b> (10 mg/day cetirizine) in addition to saline irrigation for four weeks (<a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a>). </p> </section> <section id="CD012597-sec-0092"> <h6 class="title">Saline <i>versus</i> intranasal corticosteroids </h6> <p>Seven studies compared nasal saline irrigation with intranasal steroid treatment. Intranasal steroids were: </p> <p> <ul id="CD012597-list-0019"> <li> <p>budesonide (three studies; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>); </p> </li> <li> <p>fluticasone propionate (two studies; <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>); </p> </li> <li> <p>mometasone furoate (one study; <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>); </p> </li> <li> <p>aqueous triamcinolone (one study; <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>). </p> </li> </ul> </p> <p>We considered the doses for these treatments to be within the normal clinical range and details can be found in the <a href="./references#CD012597-sec-0200" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD012597-sec-0093"> <h6 class="title">Saline <i>versus</i> intranasal antihistamines </h6> <p>One study compared saline irrigation with intranasal antihistamines (two puffs of azelastine in each nostril per day (1 puff = 0.14 mg)) for eight weeks. This study did not report any of the primary or secondary outcomes defined in the review (<a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>). </p> </section> </section> <section id="CD012597-sec-0094"> <h5 class="title">Outcomes</h5> <p>One study did not report any relevant outcomes as the aim of the study was to measure nasal cavity volumes using acoustic rhinometry (<a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>). </p> <section id="CD012597-sec-0095"> <h6 class="title">Primary outcomes</h6> <section id="CD012597-sec-0096"> <p><b>Disease severity, as measured by patient‐reported symptom score</b></p> <p>Twelve studies reported a patient‐reported disease severity score. These scores differed greatly in the method of reporting from combined visual analogue scales for all symptoms, to individual scales for up to 10 symptoms. The summary scores were also all constructed differently. Only one paper reported validation of the scales that they used (<a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>). A summary of the scales used is in <a href="#CD012597-tbl-0004">Table 2</a>. </p> <div class="table" id="CD012597-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of patient‐reported disease severity scores</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms measured</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Score for each symptom</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Summation (total range)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Notes</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Nasal symptoms'</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Visual analogue scale</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed once at end of study (0 to 10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score = worse symptoms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 3 scale</p> <p>(0 = no symptoms, 3 = severe symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total scores represented the sums of scores for the 4 symptoms (range: 0 to 12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measures of variance presented and insufficient details to impute them.</p> <p>Authors were contacted but no response was received.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Nasal discharge</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 2 scale (0 = no symptoms, 2 = intolerable symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily scores for each symptom were added together then summed for each day of the 7‐day trial period (range: 0 to 56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 4 scale (0 = no symptoms, 4 = worst symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily scores for each symptom were summed. The daily scores were averaged to calculate 'mean daily rhinitis score' per participant for each week (range: 0 to 16). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal discharge</p> <p>2. Nasal blockage</p> <p>3. Eye redness</p> <p>4. Eye itching</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 3 scale (0 = none, 3 = severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily scores for each symptom were summed. The daily scores were averaged to calculate a 'mean daily rhinitis score' per participant for each week of the pollen season (probable range: 0 to 12, see notes section). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Paper reports that the total range was 0 to 16. Authors were contacted for clarification but there was no response. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 4 scale (0 = none; 1 = slight; 2 = mild; 3 = moderate; 4 = severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily scores for each symptom were summed. The daily scores were averaged to calculate a 'mean daily rhinitis score' per participant for each week of the pollen season (range: 0 to 16). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Sneezing/itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal congestion</p> <p>4. Postnasal drip/snorting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 3 scale (0 = no symptom)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual symptom scores were summed to give a total score (range: 0 to 12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal obstruction</p> <p>2. Rhinorrhoea</p> <p>3. Sneezing</p> <p>4. Nasal pruritis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Visual analogue scale</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed once at end of study (0 to 10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score = less severe symptoms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 4 (1 = no symptoms, 4 = severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal score was calculated as the mean of the sum of scores of each nasal symptom (range: 1 to 4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rhinorrhoea was assessed by physician</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Sneezing</p> <p>2. Rhinorrhoea</p> <p>3. Blocked nose/congestion</p> <p>4. Itchy nose</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 3 (higher = worse symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom score was calculated as the sum of the individual symptoms (range: 4 to 12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Rhinorrhoea</p> <p>2. Itching</p> <p>3. Sneezing</p> <p>4. Stuffy nose</p> <p>5. Watery eyes</p> <p>6. Itching</p> <p>7. Conjunctival hyperaemia</p> <p>8. Palpebral oedema</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4‐point scale (0 = none, 3 = severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The sum of the symptom scores for each week of the study was calculated (range: 0 to 24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Night‐time symptom scores were also reported by participants but not presented in this review </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal obstruction</p> <p>2. Itching</p> <p>3. Sneezing</p> <p>4. Nasal discharge</p> <p>5. Eye itching</p> <p>6. Eye swelling</p> <p>7. Tearing</p> <p>8. Eye pain</p> <p>9. Coughing</p> <p>10. Difficulty breathing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 10 (0 = least symptoms, 10 = most symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The method for combining is not clear. The results are likely to be an average of the individual symptoms (range: 0 to 10). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD012597-sec-0097"> <p><b>Significant local adverse effects: epistaxis</b></p> <p>Adverse effects were not well reported in the studies. Only four studies specifically mentioned in their methods section that adverse effects would be routinely reported (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>). Of the 10 studies that mentioned adverse effects in their results section, six only reported on the nasal saline irrigation group (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>), and three reported on adverse effects in both study arms (<a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>). The remaining study indicated that there were withdrawals due to adverse effects but it was not clear to which groups the participants were allocated (<a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>). </p> </section> </section> <section id="CD012597-sec-0098"> <h6 class="title">Secondary outcomes</h6> <section id="CD012597-sec-0099"> <p><b>Disease‐specific health‐related quality of life</b></p> <p>Five studies measured disease‐specific health‐related quality of life. Two studies used the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) (<a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>), although the studies constructed the overall score in a different way. <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a> used the mini‐RQLQ, a shortened version of the full RQLQ, <a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a> used the Rhinasthma® questionnaire and <a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a> used a questionnaire specific to Thai allergic rhinoconjunctivitis patients (RCQ‐36). Further details of each scale can be found in the study‐specific section of the <a href="./references#CD012597-sec-0200" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD012597-sec-0100"> <p><b>Individual symptom scores</b></p> <p>No studies reported individual symptom scores.</p> </section> <section id="CD012597-sec-0101"> <p><b>Generic health‐related quality of life</b></p> <p>No studies measured generic health‐related quality of life.</p> </section> <section id="CD012597-sec-0102"> <p><b>Any other local adverse effects: local irritation, discomfort</b></p> <p>See the section above on significant local adverse effects.</p> </section> <section id="CD012597-sec-0103"> <p><b>Aural symptoms: ear pain, pressure or feeling of fullness</b></p> <p>No studies specifically mentioned aural symptoms as either a symptom of allergic rhinitis or as an adverse effect of treatment. </p> </section> <section id="CD012597-sec-0104"> <p><b>Endoscopic score</b></p> <p>Only <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a> reported the use of an endoscopy score as an outcome. This study graded the turbinate swelling on a range of 0 to 3 and reported the change at four weeks from baseline in the proportion of children with moderate to severe swelling of the turbinate. </p> </section> </section> </section> </section> <section id="CD012597-sec-0105"> <h4 class="title">Excluded studies</h4> <p>We formally excluded 29 studies (31 papers) that most closely matched the inclusion criteria (<a href="./references#CD012597-sec-0201" title="">Characteristics of excluded studies</a>). </p> <section id="CD012597-sec-0106"> <h5 class="title">Population</h5> <p>We excluded four studies as they investigated the use of saline irrigation in people with chronic rhinosinusitis, not allergic rhinitis (<a href="./references#CD012597-bbs2-0015" title="BachmannG , HommelG , MichelO . Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. European Archives of Oto‐ Rhino‐Laryngology2000;257(10):537‐41. ">Bachmann 2000</a>; <a href="./references#CD012597-bbs2-0023" title="HeatleyDG , McConnellKE , KilleTL , LeversonGE . Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngology ‐ Head and Neck Surgery2001;125(1):44‐8. ">Heatley 2001</a>; <a href="./references#CD012597-bbs2-0033" title="RabagoD , ZgierskaA , MundtM , BarrettB , BobulaJ , MaberryR . Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. Journal of Family Practice2002;51(12):1049‐55. ">Rabago 2002</a>; <a href="./references#CD012597-bbs2-0035" title="ShoseyovD , BibiH , ShaiP , ShoseyovN , ShazbergG , HurvitzH . Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. Journal of Allergy and Clinical Immunology1998;101(5):602‐5. ">Shoseyov 1998</a>). In addition, we excluded one study as despite including people with allergic rhinitis, the condition was diagnosed by symptoms and not using one of the diagnostic tests specified in our inclusion criteria (<a href="./references#CD012597-bbs2-0020" title="Chowdary GaddipattiR , RaoSP , RajivK , JainM . Isotonic nasal spray versus fluticasone nasal spray in treatment of allergic rhinitis. International Journal of Otolaryngology2017;3(3):581‐4. ">Chowdary 2017</a>). </p> </section> <section id="CD012597-sec-0107"> <h5 class="title">Intervention</h5> <p>We excluded four studies due to the wrong intervention. Two studies used thermal water rather than saline (<a href="./references#CD012597-bbs2-0018" title="BarbieriM , SalamiA , MoraF , CasazzaA , SovatzisA , TegliaR , et al. Behavior of serum IgE and IgA in patients with allergic rhinitis treated with iodine bromide thermal water. Acta Otorhinolaryngologica Italica2002;22(4):215‐9. ">Barbieri 2002</a>; <a href="./references#CD012597-bbs2-0027" title="MoraR , ChiarloneM , CrippaB , MoraF , BarbieriM . Nasal irrigations with sulphurea water in the treatment of the oral allergy syndrome. Medicina Clinica e Termale2002;14(48):287‐90. ">Mora 2002</a>), one compared saline against a non‐standard treatment for allergic rhinitis (Luffa Operculate) (<a href="./references#CD012597-bbs2-0028" title="NCT01248325 . A study of Luffa Operculate nasal solution 5mg/mL compared with saline (NaCl 09%) for the relief of nasal obstruction. https://clinicaltrials.gov/ct2/show/NCT01248325?term=NCT01248325&amp;rank=1. ">NCT01248325 2010</a>) and one used tap water, rather than saline (<a href="./references#CD012597-bbs2-0043" title="XiongM , FuXY , DengWT , LaiHW , YangCH . Tap water nasal irrigation in adults with seasonal allergic rhinitis: a randomized double‐blind study. European Archives of Oto‐Rhino‐Laryngology2014;271(6):1549‐52. ">Xiong 2014</a>). </p> </section> <section id="CD012597-sec-0108"> <h5 class="title">Study design</h5> <p>We excluded five studies because the study design was a single arm with no comparison group (<a href="./references#CD012597-bbs2-0016" title="BarberiS , D'AuriaE , BernardoL , FerraraF , PietraB , PintoF , et al. Hypertonic saline monotherapy in children with perennial allergic rhinitis: a pilot study. Journal of Biological Regulators &amp; Homeostatic Agents2016;30(1):271‐5. ">Barberi 2016a</a>; <a href="./references#CD012597-bbs2-0017" title="BarberiS , D Auria E , BernardoL , PintoF , PietraB , CiprandiG . Isotonic saline in children with perennial allergic rhinitis. Journal of Biological Regulators &amp; Homeostatic Agents2016;30(2):605‐8. ">Barberi 2016b</a>; <a href="./references#CD012597-bbs2-0024" title="JanRL . The efficacy of nasal saline aerosol purging on allergic rhinitis and rhinosinusitis patients. Allergy: European Journal of Allergy and Clinical Immunology2013;68:34. ">Jan 2013</a>; <a href="./references#CD012597-bbs2-0031" title="NguyenSA , PsaltisAJ , SchlosserRJ . Isotonic saline nasal irrigation is an effective adjunctive therapy to intranasal corticosteroid spray in allergic rhinitis. American Journal of Rhinology &amp; Allergy2014;28(4):308‐11. ">Nguyen 2014</a>; <a href="./references#CD012597-bbs2-0040" title="TomookaLT , MurphyC , DavidsonTM . Clinical study and literature review of nasal irrigation. Laryngoscope2000;110(7):1189‐93. ">Tomooka 2000</a>). </p> </section> <section id="CD012597-sec-0109"> <h5 class="title">Comparisons of saline studies</h5> <p>We excluded 15 studies (17 references) due to the comparison being between different saline solutions, rather than a comparison of saline with no saline treatment or pharmacological treatment for allergic rhinitis (<a href="./references#CD012597-bbs2-0019" title="ChiCTR‐INR‐160097782016 . A randomized, double‐blind, controlled study of the efficacy and safety of hydrogen rich saline irrigation in patients with rhinitis to improve the physiological function of nasal mucosa. http://www.chictr.org.cn/showproj.aspx?proj=16557. ">ChiCTR‐INR‐16009778 2016</a>; <a href="./references#CD012597-bbs2-0021" title="ChusakulS , WarathanasinS , SuksangpanyaN , PhannasoC , RuxrungthamS , SnidvongsK , et al. Comparison of buffered and nonbuffered nasal saline irrigations in treating allergic rhinitis. Laryngoscope2013;123(1):53‐6. ">Chusakul 2012</a>; <a href="./references#CD012597-bbs2-0022" title="DelGiudiceMM , DecimoF , MaielloN , LeonardiS , ParisiG , GolluccioM , et al. Effectiveness of ischia thermal water nasal aerosol in children with seasonal allergic rhinitis: a randomized and controlled study. International Journal of Immunopathology and Pharmacology2011;24(4):1103‐9. ">Del Giudice 2011</a>; <a href="./references#CD012597-bbs2-0025" title="LinL , YanW , ZhaoX . Treatment of allergic rhinitis with normal saline nasal irrigation at different temperature. Chinese Journal of Otorhinolaryngology Head and Neck Surgery2014;49:109‐14. ">Lin 2014</a>; <a href="./references#CD012597-bbs2-0026" title="MaliziaV , FasolaS , FerranteG , CilluffoG , MontalbanoL , LandiM , et al. Efficacy of buffered hypertonic saline nasal irrigation for nasal symptoms in children with seasonal allergic rhinitis: a randomized controlled trial. International Archives of Allergy and Immunology2017;174(2):97‐103. ">Malizia 2017</a>; <a href="./references#CD012597-bbs2-0029" title="NCT01326247 . Effectiveness of therapy with a thermal water nasal aerosol in children with seasonal allergic rhinitis. https://clinicaltrials.gov/ct2/show/NCT01326247?term=NCT01326247&amp;rank=1. ">NCT01326247 2011</a>; <a href="./references#CD012597-bbs2-0030" title="NCT02729012 . Effects of hypertonic saline solution (NACL 3%+NAHCO3) on nasal inflammation in children with AR. RinASol ‐ Pilot Study. https://clinicaltrials.gov/ct2/show/NCT02729012?term=NCT02729012&amp;rank=1. ">NCT02729012 2016</a>; <a href="./references#CD012597-bbs2-0032" title="PolasekO , HaudenschildP . A double blind cross‐over study of the effects of a nasal wash with Prorhinel by perennial rhinitis. Therapeutische Umschau1987;44(12):978‐81. ">Polasek 1987</a>; <a href="./references#CD012597-bbs2-0034" title="NCT01441778 . Efficacy of buffered hypertonic saline (BHS) nasal irrigation in allergic rhinitis (AR) children. https://clinicaltrials.gov/ct2/show/NCT01441778?term=NCT01441778&amp;rank=1. SatdhabudhaA , PoachanukoonO . Efficacy of buffered hypertonic saline nasal irrigation in children with symptomatic allergic rhinitis: a randomized double‐blind study. International Journal of Pediatric Otorhinolaryngology2012;76(4):583‐8. ">Satdhabudha 2012</a>; <a href="./references#CD012597-bbs2-0036" title="SinghR , GalagaliJR , KumarS , BahurupiY , ChandrachoodM . Comparative study of intranasal hypertonic seawater saline versus intranasal normal saline in allergic rhinitis. International Journal of Otorhinolaryngology and Head and Neck Surgery2016;3(1):104‐7. ">Singh 2016</a>; <a href="./references#CD012597-bbs2-0037" title="TCTR20150923001 . Properties of self‐prepared nasal saline irrigation and clinical outcome in patient with chronic allergic rhinitis. http://www.clinicaltrials.in.th/index.php?tp=regtrials&amp;menu=trialsearch&amp;smenu=fulltext&amp;task=search&amp;task2=view1&amp;id=1464 (first received 23 September 2015). ">TCTR20150923001 2015</a>; <a href="./references#CD012597-bbs2-0038" title="TCTR20160120001 . Efficacy and safety in self‐prepared nasal saline irrigation and clinical outcome in patient with allergic rhinitis. http://www.clinicaltrials.in.th/index.php?tp=regtrials&amp;menu=trialsearch&amp;smenu=fulltext&amp;task=search&amp;task2=view1&amp;id=1701 (first received 20 January 2016). ">TCTR20160120001 2016</a>; <a href="./references#CD012597-bbs2-0039" title="TCTR20160913003 . The efficacy of hypotonic saline and isotonic saline irrigation on nasal symptoms and mucociliary clearance in allergic rhinitis. http://www.clinicaltrials.in.th/index.php?tp=regtrials&amp;menu=trialsearch&amp;smenu=fulltext&amp;task=search&amp;task2=view1&amp;id=2066 (first received 13 September 2016). ">TCTR20160913003 2016</a>; <a href="./references#CD012597-bbs2-0041" title="UralA , OktemerTK , KizilY , IleriF , UsluS . Impact of isotonic and hypertonic saline solutions on mucociliary activity in various nasal pathologies: clinical study. Journal of Laryngology and Otology2009;123(5):517‐21. ">Ural 2009</a>; <a href="./references#CD012597-bbs2-0042" title="Efficiency of treatment of allergic rhinitis with seawater by a randomized clinical trial. http://registroclinico.sld.cu/en/trials/RPCEC00000200‐En (first received 25 September 2015). Valencia ChavezML , Soler TerranovaW , Rosique GraciaJ , Morales MuneraO . Efficacy of seawater for the treatment of allergic rhinitis: a randomized clinical trial. Social Medicine (Social Medicine Publication Group)2015;9(2):63‐72. ">Valencia Chavez 2015</a>). </p> </section> <section id="CD012597-sec-0110"> <h5 class="title">Awaiting assessment studies</h5> <p>There are four studies awaiting assessment. One study is awaiting translation (<a href="./references#CD012597-bbs2-0045" title="KrcmovaI , MalaE . Saline solutions as a supportive therapy in the concurrent treatment of allergic rhinitis. Alergie2011;13(1):66‐71. ">Krcmova 2011</a>). Three studies were published as abstracts only and the full‐text papers, or further information, could not be obtained despite attempts to contact the study authors (<a href="./references#CD012597-bbs2-0044" title="HausfeldJN . Buffered hypertonic saline nasal spray and gel as treatment modifiers in allergic and vasomotor rhinitis. Journal of Allergy and Clinical Immunology; American Academy of Allergy, Asthma and Immunology (AAAI) 63rd Annual Meeting San Diego, Ca, USA, February 23‐27. 2007; Vol. 119:S230 (Abstract 905). ">Hausfeld 2007</a>; <a href="./references#CD012597-bbs2-0046" title="LeeJ , RyuG , KimM , YangH , KimS , et al. The effects of saline nasal irrigation on allergic rhinitis and asthma in children. Allergy2017;72(S103):561. ">Lee 2017</a>; <a href="./references#CD012597-bbs2-0047" title="ManoleF . Effect of nasal irrigation in the treatment of rhinitis in children. European Academy of Allergy and Clinical Immunology and World Allergy Organization World Allergy and Asthma Congress. 2013. ">Manole 2013</a>). See <a href="./references#CD012597-sec-0202" title="">Characteristics of studies awaiting classification</a>. </p> </section> </section> </section> <section id="CD012597-sec-0111"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD012597-fig-0002">Figure 2</a> for a 'Risk of bias' graph (our judgements about each risk of bias item presented as percentages across all included studies) and <a href="#CD012597-fig-0003">Figure 3</a> for a 'Risk of bias' summary (our judgements about each risk of bias item for each included study). </p> <div class="figure" id="CD012597-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012597-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD012597-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012597-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD012597-sec-0112"> <h4 class="title">Allocation</h4> <section id="CD012597-sec-0113"> <h5 class="title">Random sequence generation</h5> <p>We assessed four studies as high risk of bias for random sequence generation.</p> <p> <ul id="CD012597-list-0020"> <li> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> did not mention the methods of randomisation in the paper and we noted that there was unequal distribution between the groups and very limited information about the baseline characteristics of the population included by allocated group. </p> </li> <li> <p><a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a> describes the participants as "randomised" in the abstract but uses the word "divided" in the methods section with no further details. In addition, there was a lack of information about baseline characteristics. </p> </li> <li> <p>In <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a> it is unclear whether the participants were randomised to study groups as the paper states that the participants were "classified" into three groups. Although baseline characteristics for age and gender were given and did not differ between groups, other baseline characteristics were not provided. </p> </li> <li> <p><a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a> states that the study was "randomised" but no methods are described and it is not even clear how many were randomised to each group. The paper also lacked baseline characteristics for the groups. </p> </li> </ul> </p> <p>We assessed two studies as having unclear risk of bias as the papers indicated that the participants were "randomised" but no details of the methods are presented (<a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>). </p> <p>We assessed the remaining eight studies as at low risk of bias for random sequence generation. </p> </section> <section id="CD012597-sec-0114"> <h5 class="title">Allocation concealment</h5> <p>One study had a high risk of allocation concealment bias, as there were an unequal number of participants in each arm and no baseline characteristics are provided so there is a concern that the investigators may have known the group to which they were allocating participants (<a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>). </p> <p>There were 10 studies that did not provide any information about the methods used to ensure that the investigators allocating participants to the groups could not influence the allocation and we assessed these as having unclear risk of bias (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>; <a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>; <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>; <a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>; <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>). </p> <p>The remaining three studies were at low risk of allocation concealment bias.</p> </section> </section> <section id="CD012597-sec-0115"> <h4 class="title">Blinding</h4> <section id="CD012597-sec-0116"> <h5 class="title">Blinding of participants and personnel</h5> <p>We judged all of the studies to be at high risk of bias. Thirteen studies were non‐blinded and many of these compared saline with no saline treatment so there were practical issues that meant blinding of participants would not have been possible. <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a> describes their study in the abstract as "single‐blinded" but does not provide details of which aspect of the trial this relates to as the three different trial arms had different regimens: the saline was given three times daily whereas the steroid was given once daily and no placebo is mentioned. We assessed this as insufficient protection from participants and personnel from knowing the treatment group to which they were allocated. </p> </section> <section id="CD012597-sec-0117"> <h5 class="title">Blinding of outcome assessors</h5> <p>We assessed all of the included studies to be at high risk of bias. None of the studies mentioned that the outcome assessors were blinded to treatment group. As most of the outcomes were participant‐reported, and the participants were not blinded, blinding of outcome assessors was not possible. </p> </section> </section> <section id="CD012597-sec-0118"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed two studies to be at high risk of attrition bias due to a rate of withdrawal above 25%. In <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>, 29% of participants withdrew but the authors did not provide any reasons for withdrawals or state whether there were differences between groups. <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a> noted that 25% of the participants in the no saline treatment group did not complete the study. The dropout rate was imbalanced between the groups although reasons were provided. More people dropped out of the no saline treatment group because of the use of rescue medications. </p> <p>One study was at unclear risk of bias as although no withdrawals were mentioned the paper did not provide enough information to determine whether all the participants included in the study completed (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>). </p> <p>We assessed the remaining 11 studies as at low risk of bias.</p> </section> <section id="CD012597-sec-0119"> <h4 class="title">Selective reporting</h4> <p>We assessed three studies as at high risk of reporting bias. <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> had incomplete reporting of outcomes in the paper. <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a> was the only study that reported withdrawals due to adverse effects, yet failed to provide information about the nature of the effects or in which treatment groups they occurred. <a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a> failed to report any measures of variation for their results. </p> <p>One study was at unclear risk of selective reporting bias (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>). One outcome was mentioned in the results section (use of antibiotics) but was not identified in the methods section. In addition, there was some confusion between the published abstract and the draft full paper (provided by personal communication with the authors) regarding which quality of life instrument was used. </p> <p>We assessed the remaining 10 studies as at low risk of selective reporting as, despite not having a protocol available, all of the outcomes mentioned in their methods sections were reported in the results. </p> </section> <section id="CD012597-sec-0120"> <h4 class="title">Other potential sources of bias</h4> <section id="CD012597-sec-0121"> <h5 class="title">Use of non‐validated instruments</h5> <p>We assessed three studies as at low risk of bias. In <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>, references were provided for the papers reporting validation of the different outcomes. <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a> did not report any relevant outcomes. In <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>, the only outcome of relevance that was reported had been measured using a validated scale. </p> <p>We assessed the remaining 11 studies as at unclear risk of bias because they did not mention the validation of the instruments used to measure the patient‐reported disease severity score. In addition, <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> and <a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a> appeared to use variations of validated health‐related quality of life scales but did not discuss the impact that this may have had on the results. </p> </section> <section id="CD012597-sec-0122"> <h5 class="title">Other bias</h5> <p>A general lack of information provided in two papers led to them being assessed as having unclear risk of other bias (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>). </p> <p>We identified no other sources of bias in the remaining 12 studies.</p> </section> <section id="CD012597-sec-0123"> <h5 class="title">Funding sources</h5> <p>Funding was mentioned in seven studies. Two studies reported that no external financial support was received (<a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>). Five studies received funding from national or regional governmental funds (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>; <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>). </p> <p>No information was provided about funding in the remaining seven studies.</p> </section> <section id="CD012597-sec-0124"> <h5 class="title">Declarations of interest</h5> <p>Four studies made a declaration in the paper that none of the authors had conflicts of interest (<a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>; <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>). None of the 10 remaining studies provide any declarations of interest. </p> </section> </section> </section> <section id="CD012597-sec-0125"> <h3 class="title" id="CD012597-sec-0125">Effects of interventions</h3> <p>See: <a href="./full#CD012597-tbl-0001"><b>Summary of findings for the main comparison</b> Saline versus no saline treatment for allergic rhinitis</a>; <a href="./full#CD012597-tbl-0002"><b>Summary of findings 2</b> Saline irrigation plus pharmacological treatment versus pharmacological treatment alone for allergic rhinitis</a> </p> <section id="CD012597-sec-0126"> <h4 class="title">Comparison 1. Saline versus no saline treatment</h4> <p>Seven studies (444 participants) compared saline treatment with no saline treatment. Four used hypertonic saline (<a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>) and one used isotonic solution (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>). One study did not provide details of tonicity (<a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>). One study included two saline groups, one using isotonic saline and one using hypertonic saline (<a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>); for the initial analyses we combined these saline groups. </p> <section id="CD012597-sec-0127"> <h5 class="title">1.1. Disease severity, as measured by patient‐reported symptom score</h5> <p>All seven studies presented data for disease severity using a number of different scales; a summary can be found in <a href="#CD012597-tbl-0004">Table 2</a>. </p> <p>One study asked participants to rate their "overall nasal symptoms" on a 0 to 10 visual analogue scale (lower score = WORSE symptoms) (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>). </p> <p>Five of the remaining six studies asked participants to measure the same symptoms: rhinorrhoea, nasal blockage, nasal itching and sneezing (<a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a>; <a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>; <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>). One study recorded different symptoms (nasal discharge, nasal blockage, eye redness, eye itching) (<a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>). </p> <p>Due to the differences in the scales used, we used a standardised mean difference (SMD) in the analysis. </p> <section id="CD012597-sec-0128"> <h6 class="title">Up to four weeks</h6> <p>Six studies reported results at up to four weeks. The results showed that people using saline irrigation had lower symptom scores than people in the no saline treatment group (SMD ‐1.32, 95% confidence interval (CI) ‐1.84 to ‐0.81; 407 participants; 6 studies; I<sup>2</sup> = 75%) (<a href="./references#CD012597-fig-0004" title="">Analysis 1.1</a>). Due to the statistical heterogeneity identified, we used a random‐effects model. The heterogeneity was driven mainly by the large apparent effect in <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>. Removing this study reduced the heterogeneity to a low level and the result still significantly favoured the use of saline irrigation. This SMD represents a large effect size and translates into a decrease of approximately 1.97 points (1.21 to 2.74) on a 0‐ to 10‐point visual analogue scale for nasal symptoms (lower = better) (<i>low‐quality evidence</i>). </p> <p>Subgroup analysis results show that both <b>children</b> (SMD ‐1.07, 95% CI ‐1.39 to ‐0.74; 322 participants; 4 studies; I<sup>2</sup> = 25%) and <b>adults</b> (SMD ‐2.06, 95% CI ‐3.80 to ‐0.32; 85 participants; 2 studies; I<sup>2</sup> = 90%) reported improved symptoms with saline compared to no saline. There was no evidence of a difference between the age subgroups. </p> <p><b>Four weeks to six months</b> </p> <p>Five studies reported results at between six and eight weeks. The results showed that people using saline irrigation had lower symptom scores than people in the no saline group (SMD ‐1.44, 95% CI ‐2.39 to ‐0.48; 167 participants; 5 studies; I<sup>2</sup> = 86%) (<a href="./references#CD012597-fig-0005" title="">Analysis 1.2</a>). We used a random‐effects model due to the presence of statistical heterogeneity. The heterogeneity did not reduce after removing <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a> and the result still significantly favoured the use of saline irrigation. This SMD represents a large effect size and translates into a decrease of approximately 2.98 points (0.99 to 5.98) on a 0‐ to 10‐point visual analogue scale for nasal symptoms (lower = better) (<i>low‐quality evidence</i>). </p> <p>Subgroup analysis show that both <b>children</b> (SMD ‐1.06, 95% CI ‐2.13 to 0.01; 102 participants; 3 studies; I<sup>2</sup> = 83%) and <b>adults</b> (SMD ‐2.02, 95% CI ‐3.79 to ‐0.25; 65 participants; 2 studies; I<sup>2</sup> = 87%) reported improved symptoms with saline compared to no saline, but there was no evidence of a difference between the subgroups for the different ages. </p> </section> </section> <section id="CD012597-sec-0129"> <h5 class="title">1.2. Significant local adverse effects: epistaxis</h5> <p>Three studies reported methods for collecting information about adverse effects in their methods section (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>). Five studies made a statement about adverse effects in their results section. Of these, two studies (240 children) reported that there were no adverse effects in either of the treatment groups although epistaxis was not specifically mentioned as being sought (<i>low‐quality evidence</i>) (<a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>). The remaining three studies only provided information that no adverse effects were reported in the saline treatment arm (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>). </p> </section> <section id="CD012597-sec-0130"> <h5 class="title">1.3. Disease‐specific health‐related quality of life</h5> <p>One study (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; 42 children) reported disease‐specific health‐related quality of life using the Thai Rhinoconjunctivitis Quality of Life scale (RCQ‐36). This questionnaire has 36 items each measured on a 0 to 4 scale, however only 35 items were used in this study (range 0 to 140), higher score = worse quality of life. </p> <section id="CD012597-sec-0131"> <h6 class="title">Up to four weeks</h6> <p>It is uncertain whether there is an improvement in disease‐specific quality of life with saline irrigation compared with no saline treatment at four weeks in children (mean difference (MD) ‐3.32, 95% CI ‐11.35 to 4.71; 42 participants; 1 study) (<a href="./references#CD012597-fig-0006" title="">Analysis 1.3</a>) <i>(very low‐quality evidence</i>). </p> </section> <section id="CD012597-sec-0132"> <h6 class="title">Four weeks to six months</h6> <p>It is uncertain whether there is an improvement in disease‐specific quality of life with saline irrigation compared with no saline treatment at eight weeks in children (MD ‐2.06, 95% CI ‐8.38 to 4.26; 42 participants; 1 study) (<a href="./references#CD012597-fig-0006" title="">Analysis 1.3</a>) <i>(very low‐quality evidence</i>). </p> </section> </section> <section id="CD012597-sec-0133"> <h5 class="title">1.4. Individual symptom scores</h5> <p>No studies reported symptom scores for the individual symptoms of anterior rhinorrhoea (runny nose), posterior rhinorrhoea (post‐nasal drip), nasal blockage/congestion/obstruction, nasal itching or sneezing. </p> </section> <section id="CD012597-sec-0134"> <h5 class="title">1.5. Generic health‐related quality of life</h5> <p>No studies reported generic health‐related quality of life.</p> </section> <section id="CD012597-sec-0135"> <h5 class="title">1.6. Any other local adverse effects: local irritation, discomfort</h5> <p>Five studies made a statement about adverse effects. Two studies (240 children) reported that no adverse effects were experienced in either of the treatment groups (<a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a>; <a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>), although it is unclear whether the specific adverse effects of local irritation and discomfort were sought (<i>low‐quality evidence</i>). </p> <p>The remaining three studies (68 children, 44 adults) reported that there were no adverse effects in the 'active' treatment group (i.e. saline irrigation) although again it is unclear whether the specific adverse effects of local irritation and discomfort were sought (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>; <a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a>; <a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a>). </p> </section> <section id="CD012597-sec-0136"> <h5 class="title">1.7. Aural symptoms: ear pain, pressure or feeling of fullness</h5> <p>No studies reported aural symptoms.</p> </section> <section id="CD012597-sec-0137"> <h5 class="title">1.8. Endoscopic score (e.g. Lund‐Mackay/Lund‐Kennedy)</h5> <p>No studies reported endoscopy scores (for example, Lund‐Mackay or Lund‐Kennedy).</p> <p>One study (220 children) reported the change from baseline at four weeks in the proportion of children with moderate to severe swelling of the turbinates. The group using hypertonic saline irrigation showed a significant reduction in the percentage of children with moderate to severe turbinate swelling (‐31.2%, 95% CI ‐16.5% to ‐46.0%), whereas the groups using isotonic saline and no saline irrigation both showed a non‐significant reduction in the proportion of children with moderate to severe turbinate swelling (‐5.1%, 95% CI ‐9.9% to 19.9% and ‐5.0%, 95% CI ‐11.9% to 21.9%, respectively) (<a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>). </p> </section> </section> <section id="CD012597-sec-0138"> <h4 class="title">Subgroup analysis</h4> <p>We stated in the protocol that analyses would be completed with regards to the volume, tonicity and alkalinity of the solution, irrespective of statistical heterogeneity. The only outcome that had enough data to be included in the subgroup analysis was that of patient‐reported disease severity. It should be noted that there is statistical heterogeneity within these results, which is probably due to the different scoring systems used and so all of the results must be treated with caution. </p> <section id="CD012597-sec-0139"> <h5 class="title">Volume</h5> <p>When we classified the results into volume subgroups, all of the saline volume categories showed improvement in patient‐reported disease severity compared with no saline treatment at <b>up to four weeks</b>: </p> <p> <ul id="CD012597-list-0021"> <li> <p>Very low‐volume saline (less than 5 mL/nostril per application): SMD ‐0.96, 95% CI ‐1.39 to ‐0.52; 100 participants; 3 studies; I<sup>2</sup> = 5%. </p> </li> <li> <p>Low‐volume saline (between 5 mL and 60 mL/nostril per application): SMD ‐2.07, 95% CI ‐3.73 to ‐0.42; 265 participants; 2 studies; I<sup>2</sup> = 92%. </p> </li> <li> <p>High‐volume saline (more than 60 mL/nostril per application): SMD ‐0.92, 95% CI ‐1.56 to ‐0.28; 42 participants; 1 study. </p> </li> </ul> </p> <p>See <a href="./references#CD012597-fig-0014" title="">Analysis 4.1</a>. </p> <p>The results for <b>four weeks to six months</b> (range of follow‐up six to eight weeks) were as follows: </p> <p> <ul id="CD012597-list-0022"> <li> <p>Very low‐volume saline (less than 5 mL/nostril per application): SMD ‐1.33, 95% CI ‐2.22 to ‐0.44; 80 participants; 3 studies; I<sup>2</sup> = 67%. </p> </li> <li> <p>Low‐volume saline (between 5 mL and 60 mL/nostril per application): SMD ‐2.91, 95% CI ‐3.77 to ‐2.05; 45 participants; 1 study. </p> </li> <li> <p>High‐volume saline (more than 60 mL/nostril per application): SMD ‐0.41, 95% CI ‐1.02 to 0.21; 42 participants; 1 study. </p> </li> </ul> </p> <p>See <a href="./references#CD012597-fig-0015" title="">Analysis 4.2</a>. </p> <p>The tests for subgroup differences did not indicate statistical differences between the subgroups at either time point. </p> </section> <section id="CD012597-sec-0140"> <h5 class="title">Tonicity</h5> <p>For this subgroup analysis we separated out the results for the three‐arm trial comparing two different saline solutions (hypertonic and isotonic saline) with no saline treatment (<a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a>), but we split the denominator in the no saline treatment group between the comparisons in the two separate groups to ensure that people in the no saline treatment group were not counted twice. </p> <p>When we classified the results into tonicity subgroups, all of the saline tonicity categories showed improvement in patient‐reported disease severity compared with no saline treatment at <b>up to four weeks</b>: </p> <p> <ul id="CD012597-list-0023"> <li> <p>Isotonic or 'normal' saline (0.9%): SMD ‐0.82, 95% CI ‐1.18 to ‐0.47; 152 participants; 2 studies; I<sup>2</sup> = 0%. </p> </li> <li> <p>Hypertonic saline (&gt; 0.9%): SMD ‐1.72, 95% CI ‐2.62 to ‐0.82; 255 participants; 5 studies; I<sup>2</sup> = 87%. </p> </li> </ul> </p> <p>See <a href="./references#CD012597-fig-0016" title="">Analysis 5.1</a>. </p> <p>The results for between <b>four weeks and six months</b> (range of follow‐up six to eight weeks) were as follows: </p> <p> <ul id="CD012597-list-0024"> <li> <p>Isotonic or 'normal' saline (0.9%): SMD ‐0.41, 95% CI ‐1.02 to 0.21; 42 participants; 1 study. </p> </li> <li> <p>Hypertonic saline (&gt; 0.9%): SMD ‐1.91, 95% CI ‐3.14 to ‐0.68; 105 participants; 3 studies; I<sup>2</sup> = 84%. </p> </li> </ul> </p> <p>See <a href="./references#CD012597-fig-0017" title="">Analysis 5.2</a>. </p> <p>In both instances the effect size for treatment with hypertonic solution was greater than with normal saline. The tests for subgroup differences did not indicate statistical differences at up to four weeks, but did suggest that there may have been a difference at between four weeks and six months (P = 0.03, I<sup>2</sup> = 78.3%). However, it can seen that there is considerable heterogeneity in the results of the group using hypertonic saline. </p> </section> <section id="CD012597-sec-0141"> <h5 class="title">Alkalinity</h5> <p>The alkalinity of solutions was not well reported in the studies and so it was not possible to undertake this subgroup analysis. </p> <p>No further subgroup analyses were undertaken.</p> </section> </section> <section id="CD012597-sec-0142"> <h4 class="title">Comparison 2. Adding saline irrigation to pharmacological treatment</h4> <p>Three studies (119 participants) compared saline irrigation with intranasal steroids against intranasal steroids alone. One study (14 adults) compared saline irrigation with oral antihistamine against oral antihistamines alone. </p> <section id="CD012597-sec-0143"> <h5 class="title">2.1. Disease severity, as measured by patient‐reported symptom score</h5> <p>Four studies reported this outcome (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>). <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> did not present sufficient data in the paper to use in the meta‐analysis and no response was received after we attempted to contact the author, so only narrative results are presented. Each of the studies included in the meta‐analysis used different scoring mechanisms and included different symptoms (<a href="#CD012597-tbl-0004">Table 2</a>): </p> <p> <ul id="CD012597-list-0025"> <li> <p><a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a> and <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>: reported four symptoms each measured on a four‐point scale (0 to 3 scale, 0 = no symptoms). The sum of the scores gave a total score (total range 0 to 12). </p> </li> <li> <p><a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a>: reported eight symptoms each measured on a four‐point scale (0 to 3, 0 = no symptoms). The sum of the symptom scores was calculated (total range 0 to 24). </p> </li> <li> <p><a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>: reported 10 symptoms each measured on a 0 to 10 visual analogue scale (VAS) (0 = least symptoms). These scores were averaged to give a final range of 0 to 10. </p> </li> </ul> </p> <section id="CD012597-sec-0144"> <h6 class="title">Up to four weeks</h6> <p>Two studies (18 children, 14 adults) reported patient‐reported disease severity at up to four weeks. In one study all participants also used oral antihistamines (<a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a>), and in the other study all participants also used intranasal steroids (<a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>). It is uncertain whether saline irrigation in addition to pharmacological treatment (oral antihistamines or intranasal steroids) improved symptom scores at four weeks compared with pharmacological treatment alone (SMD ‐0.60, 95% CI ‐1.34 to 0.15; 32 participants; 2 studies; I<sup>2</sup> = 0%) (<a href="./references#CD012597-fig-0007" title="">Analysis 2.1</a>)<i>(very low‐quality evidence</i>). </p> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> reported higher mean values for disease severity (more severe symptoms) in the intranasal steroid group (4.16, 17 children), compared with the group receiving saline and intranasal steroids (3.26, 26 children) at four weeks using an instrument with a total range of 0 to 12. The authors reported that there was a significant difference between groups (P &lt; 0.05) but they did not provide information on the variance of the results and no response was received from the author after a request for further information. </p> </section> <section id="CD012597-sec-0145"> <h6 class="title">Four weeks to six months</h6> <p>Two studies (18 children; 40 adults) in which all participants also used intranasal steroids reported patient‐reported diease severity at three months (<a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>). It is uncertain whether saline irrigation in addition to intranasal steroids improved symptom scores at three months compared with pharmacological treatment alone (SMD ‐0.32, 95% CI ‐0.85 to 0.21; 58 participants; 2 studies; I<sup>2</sup> = 0%) (<a href="./references#CD012597-fig-0008" title="">Analysis 2.2</a>) (<i>very low‐quality evidence</i>). </p> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> reported higher mean values for disease severity (more severe symptoms) in the intranasal steroid group (4.27, 17 children) compared with the group receiving saline and intranasal steroids (3.37, 26 children) at three months using an instrument with a total range of 0 to 12. </p> </section> </section> <section id="CD012597-sec-0146"> <h5 class="title">2.2. Significant local adverse effects: epistaxis</h5> <p>None of the studies specifically mentioned how adverse effects would be sought in their study methods; nor did they mention epistaxis as an adverse effect. Three studies made statements about adverse effects. One study (40 adults) indicated that "<i>all</i> [treatments were]<i>tolerated well, none</i> [of the participants] <i>had adverse events</i>" (<a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>) and the other two studies (62 children) reported that nasal irrigation with saline was well accepted in all patients and no adverse effects were reported in the saline group (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>) (<i>very low‐quality evidence</i>). </p> </section> <section id="CD012597-sec-0147"> <h5 class="title">2.3. Disease‐specific health‐related quality of life</h5> <p>Two studies including only adults measured disease‐specific health‐related quality of life at between four weeks and three months. </p> <p><a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a>, where all participants also used oral antihistamines, used the Rhinasthma quality of life instrument (range 0 to 100, lower = better quality of life) at four weeks. We present the results for the 'global impact', which is a synthetic score covering the entire questionnaire. Standard deviations for the results were not presented and so we imputed these from the P values. </p> <p><a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>, where all participants also used intranasal steroids, used the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) (unclear range, lower = better quality of life) at three months. </p> <p>Due to these differences, we used the SMD in the analysis.</p> <section id="CD012597-sec-0148"> <h6 class="title">Four weeks to six months</h6> <p>It is uncertain whether saline irrigation in addition to pharmacological treatment (oral antihistamines or intranasal steroids) improved health‐related quality of life at four weeks to three months compared with pharmacological treatment alone (SMD ‐1.26, 95% CI ‐2.47 to ‐0.05; 54 adult participants; 2 studies; I<sup>2</sup> = 63%). We used a random‐effects model due to statistical heterogeneity (<a href="./references#CD012597-fig-0009" title="">Analysis 2.3</a>) (<i>very low‐quality evidence</i>). </p> </section> </section> <section id="CD012597-sec-0149"> <h5 class="title">2.4. Individual symptom scores</h5> <p>No studies reported symptom scores for the individual symptoms of anterior rhinorrhoea (runny nose), posterior rhinorrhoea (post‐nasal drip), nasal blockage/congestion/obstruction, nasal itching or sneezing. </p> </section> <section id="CD012597-sec-0150"> <h5 class="title">2.5. Generic health‐related quality of life</h5> <p>No studies reported generic health‐related quality of life.</p> </section> <section id="CD012597-sec-0151"> <h5 class="title">2.6. Any other local adverse effects: local irritation, discomfort</h5> <p>None of the studies specifically mentioned local irritation or discomfort as an adverse effect. Two studies made statements about adverse effects. One (40 adults) indicated that "<i>all</i> [treatments were]<i>tolerated well, none</i> [of the participants] <i>had adverse events</i>" (<a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>) and the other (18 children) stated that "<i>Nasal irrigation with saline was well accepted in all patients and no adverse effect was reported”</i> (<a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>) (<i>very low‐quality evidence</i>). </p> </section> <section id="CD012597-sec-0152"> <h5 class="title">2.7. Aural symptoms: ear pain, pressure or feeling of fullness</h5> <p>No studies reported aural symptoms of ear pain, pressure or feeling of fullness.</p> </section> <section id="CD012597-sec-0153"> <h5 class="title">2.8. Endoscopic score (e.g. Lund‐Mackay/Lund‐Kennedy)</h5> <p>No studies reported endoscopic scores.</p> </section> </section> <section id="CD012597-sec-0154"> <h4 class="title">Comparison 3. Saline versus intranasal steroids</h4> <p>Seven studies (89 children, 129 adults) compared saline nasal irrigation with intranasal steroids (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>; <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>; <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>), although <a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a> (40 children) did not report any of the primary or secondary outcomes for this review. </p> <p>One study included two saline arms (hypertonic and normal saline) (<a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a>), for which we combined the results for these analyses. </p> <section id="CD012597-sec-0155"> <h5 class="title">3.1. Disease severity, as measured by patient‐reported symptom score</h5> <p>Five studies measured disease severity using a patient‐reported symptom score (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>; <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a><a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a>; <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>). </p> <p>Two of these studies could not be included in the quantitative results: <a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> did not present sufficient data in the paper to be used in the meta‐analysis and no response was received after we attempted to contact the author, therefore only narrative results are presented. <a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a> used median values and interquartile ranges to describe the results in the intranasal steroid arm, and means with standard deviations in the arm receiving saline. </p> <p>Each of the three studies included in the quantitative results used different scales, which are summarised in <a href="#CD012597-tbl-0004">Table 2</a>. </p> <p> <ul id="CD012597-list-0026"> <li> <p><a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>: Four symptoms: sneezing/itching, rhinorrhoea, nasal congestion and postnasal drip/snorting, each measured on a four‐point scale (0 to 3 scale, 0 = no symptom). The sum of the scores gave a total score (total range 0 to 12). </p> </li> <li> <p><a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>: Four symptoms: nasal obstruction, rhinorrhoea, sneezing and nasal pruritis, measured as a "total nasal score" on a visual analogue scale (0 to 10). </p> </li> <li> <p><a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>: Ten symptoms: nasal obstruction, itching, sneezing, nasal discharge, eye itching, eye swelling, tearing, eye pain, coughing and difficulty breathing, each measured on a 0 to 10 visual analogue scale (VAS) (0 = least symptoms). These scores were averaged to give a final range of 0 to 10. </p> </li> </ul> </p> <p>Due to these differences, when we performed meta‐analyses that included more than one study we used the SMD. </p> <section id="CD012597-sec-0156"> <h6 class="title">Up to four weeks</h6> <p>One study (14 children) presented results for symptom severity. It is uncertain whether there is a difference in symptom severity score between the intranasal steroid and the saline irrigation groups at four weeks (MD 1.06, 95% CI ‐1.65 to 3.77) (<a href="./references#CD012597-fig-0010" title="">Analysis 3.1</a>). </p> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> reported higher mean values for disease severity (more severe symptoms) in the saline group (5.44, 18 children) compared with the intranasal steroid group (4.11, 17 children) at four weeks using an instrument with a total range of 0 to 12. </p> </section> <section id="CD012597-sec-0157"> <h6 class="title">Four weeks to six months</h6> <p>Three studies (83 adults, 14 children) showed that intranasal steroids may improve patient‐reported symptom scores compared with saline irrigation at four weeks to three months (SMD 1.26, 95% CI ‐0.92 to 3.43; 97 participants; three studies; I<sup>2</sup> = 95%). We used a random‐effects model due to unexplained heterogeneity (<a href="./references#CD012597-fig-0011" title="">Analysis 3.2</a>). </p> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> reported higher mean values for disease severity (more severe symptoms) in the saline group (6.58, 18 children) compared with the intranasal steroid group (4.27, 17 children) at 12 weeks using an instrument with a total range of 0 to 12. </p> </section> </section> <section id="CD012597-sec-0158"> <h5 class="title">3.2. Significant local adverse effects: epistaxis</h5> <p>One study reported the recording of adverse effects in their methods section although epistaxis was not specifically mentioned as being sought or identified in any of the studies. Of the five studies that mentioned adverse effects in their results, <a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a> (21 adults) reported that two participants withdrew from the study due to adverse effects but they did not provide further information as to the nature of the effects or to which groups the participants were allocated. <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> (38 adults) mentioned that all treatments were "<i>well tolerated</i>" and <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a> (45 adults) reported that none of the saline irrigation group experienced adverse effects but that 27.3% of the intranasal steroid group reported adverse effects (although none were reported as epistaxis). The remaining two studies only noted that there were no adverse effects in the saline irrigation group; there was no information for the groups allocated to intranasal steroids (<a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a>; <a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>). </p> </section> <section id="CD012597-sec-0159"> <h5 class="title">3.3. Disease‐specific health‐related quality of life</h5> <p>Two studies reported disease‐specific health‐related quality of life:</p> <p> <ul id="CD012597-list-0027"> <li> <p><a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>: used the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) (unclear range, lower = better quality of life). </p> </li> <li> <p><a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a>: used the mini‐RQLQ, a shortened version of the RQLQ tool (0 to 84, lower = better quality of life). </p> </li> </ul> </p> <p>Due to these differences, when we performed meta‐analyses that included more than one study we used the SMD. </p> <section id="CD012597-sec-0160"> <h6 class="title">Four weeks to six months</h6> <p>Two studies (83 adults) indicated that it is uncertain whether there is a difference in disease‐specific quality of life between the saline irrigation and intranasal steroid groups at three months (SMD 0.01, 95% CI ‐0.73 to 0.75; 83 participants; 2 studies; I<sup>2</sup> = 65%). We used a random‐effects model due to heterogeneity (<a href="./references#CD012597-fig-0012" title="">Analysis 3.3</a>). </p> </section> </section> <section id="CD012597-sec-0161"> <h5 class="title">3.4. Individual symptom scores</h5> <p>No studies reported symptom scores for the individual symptoms of anterior rhinorrhoea (runny nose), posterior rhinorrhoea (post‐nasal drip), nasal blockage/congestion/obstruction, nasal itching or sneezing. </p> </section> <section id="CD012597-sec-0162"> <h5 class="title">3.5. Generic health‐related quality of life</h5> <p>No studies reported generic health‐related quality of life.</p> </section> <section id="CD012597-sec-0163"> <h5 class="title">3.6. Any other local adverse effects: local irritation, discomfort</h5> <p>See section 3.2 above. Only <a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a> (45 adults) specifically mentioned local irritation or discomfort, where 6/22 (27.3%) of participants using intranasal steroids reported pharyngitis (sore throat) compared to no reports in the group using saline treatment (risk ratio (RR) 0.07, 95% CI 0.00 to 1.24) (<a href="./references#CD012597-fig-0013" title="">Analysis 3.4</a>). </p> </section> <section id="CD012597-sec-0164"> <h5 class="title">3.7. Aural symptoms: ear pain, pressure or feeling of fullness</h5> <p>No studies reported aural symptoms of ear pain, pressure or feeling of fullness.</p> </section> <section id="CD012597-sec-0165"> <h5 class="title">3.8. Endoscopic score (e.g. Lund‐Mackay/Lund‐Kennedy)</h5> <p>No studies reported endoscopic scores.</p> </section> </section> <section id="CD012597-sec-0166"> <h4 class="title">Comparison 4. Saline versus intranasal antihistamines</h4> <p>One study (40 children) compared saline irrigation with intranasal antihistamines but did not report any of the primary or secondary outcomes of this review (<a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012597-sec-0167" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012597-sec-0167">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012597-sec-0237">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012597-sec-0167"></div> <section id="CD012597-sec-0168"> <h3 class="title" id="CD012597-sec-0168">Summary of main results</h3> <p>This review includes seven studies comparing nasal saline irrigation with no saline treatment where no background pharmacological treatment was used (<a href="./full#CD012597-tbl-0001">summary of findings Table for the main comparison</a>), and four studies comparing saline irrigation with no saline treatment where all participants used pharmacological treatment for allergic rhinitis (intranasal steroids: three studies; oral antihistamines: one study) (<a href="./full#CD012597-tbl-0002">summary of findings Table 2</a>). </p> <p>Seven studies compared nasal saline irrigation against intranasal steroid treatment. One study compared saline irrigation against intranasal antihistamines but no relevant outcomes were presented. </p> <section id="CD012597-sec-0169"> <h4 class="title">Saline <i>versus</i> no saline treatment (no background treatment) </h4> <p>There may be an improvement in patient‐reported disease severity with saline irrigation compared to no saline treatment at up to four weeks and at up to eight weeks (<i>low‐quality evidence</i> ). It is uncertain whether there are differences between the saline and no saline groups with respect to disease‐specific health‐related quality of life at up to four weeks and at eight weeks (<i>very low‐quality evidence</i> ). Of the five studies that made statements about adverse effects, no adverse effects were reported in either the saline arms (five studies) or no saline arms (two studies) (<i>low‐quality evidence</i>). No other prespecified outcomes were reported. </p> <p>Subgroup analysis for volume indicated that all of the volumes of saline irrigation may have reduced patient symptom severity but there was significant heterogeneity within the results. With respect to tonicity, the effect size for treatment with hypertonic solution was greater than with normal saline, although there was considerable heterogeneity in the results. </p> </section> <section id="CD012597-sec-0170"> <h4 class="title">Saline plus pharmacological treatment versus pharmacological treatment alone (intranasal steroids or oral antihistamines) </h4> <p>It is uncertain whether there are differences between saline irrigation and no saline treatment, when used alongside pharmacological treatment, in patient‐reported disease severity or disease‐specific health‐related quality of life (<i>very low‐quality evidence</i>). No adverse effects were reported. No other outcomes were reported. </p> </section> <section id="CD012597-sec-0171"> <h4 class="title">Saline versus intranasal steroids</h4> <p>It is uncertain whether there are differences between saline and intranasal steroid treatment for any of the outcomes reported. The quality of the evidence is <i>very low</i>. </p> </section> </section> <section id="CD012597-sec-0172"> <h3 class="title" id="CD012597-sec-0172">Overall completeness and applicability of evidence</h3> <p>The evidence included studies in both children and adults, including a study in pregnant women. The included saline solutions varied greatly with respect to the volume and tonicity of saline and are likely to be representative of the solutions available in practice. </p> <p>Adverse effects were not well reported in the included studies. In many studies the methods section did not detail how adverse effects would be defined or recorded, and in many the results just included one statement indicating that 'no adverse effects were reported'. There have been adverse effects reported in other populations using nasal saline irrigation. Cochrane Reviews investigating the use of nasal saline irrigation in people with other conditions have noted the adverse effects of epistaxis and local irritation/discomfort (<a href="./references#CD012597-bbs2-0054" title="ChongLY , HeadK , HopkinsC , PhilpottC , GlewS , ScaddingG , et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database of Systematic Reviews2016, Issue 4. [DOI: 10.1002/14651858.CD011995.pub2] ">Chong 2016</a>; <a href="./references#CD012597-bbs2-0064" title="KingD , MitchellB , WilliamsCP , SpurlingGKP . Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD006821.pub3] ">King 2015</a>). The author team have identified that in addition to nasal symptoms, people with allergic rhinitis using saline irrigation may also complain of aural symptoms, which could influence their adherence. </p> <p>The maximum duration of treatment in the studies was three months and so it is not known whether the efficacy in reducing symptoms is maintained over a longer period, or if there are longer‐term adverse effects that were not reported in the studies. </p> </section> <section id="CD012597-sec-0173"> <h3 class="title" id="CD012597-sec-0173">Quality of the evidence</h3> <p>The quality of the evidence for the outcomes as assessed with GRADE is <i>low</i> or <i>very low.</i> The studies were generally small with poor description of methodology. The lack of information about the validation of instruments used to assess patient‐reported disease severity limited our confidence in the results. It is likely that the variety of different saline interventions used within the studies (volumes, tonicity, duration of treatment), and differences in the disease severity scores, resulted in the heterogeneity observed in the results. </p> </section> <section id="CD012597-sec-0174"> <h3 class="title" id="CD012597-sec-0174">Potential biases in the review process</h3> <p>Four of the studies were conducted in China, two of which required translation from Chinese. There may have been other studies published in the Chinese literature that were not identified through our searches. </p> <p>For the comparison of saline irrigation with no saline treatment, this review did not look at the number of people who required the use of rescue medication during the study, although a number of studies did state that rescue medication (usually oral antihistamines) was allowed. If there was a variation between the two treatment groups with regards to the number requiring rescue medication this may have had an impact on the effect sizes reported, although this is likely to increase the effect size for saline irrigation compared to no saline treatment. Future updates could consider taking this into account; for example, the Chairattananon study used a combined 'nasal symptom and medication' score, which helped to account for this (<a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a>). </p> <p>We did not include studies using saline as a 'placebo' treatment in comparison to 'active' allergic rhinitis treatments (such as intranasal steroids). In these studies, which are looking primarily at the efficacy and safety of the 'active' treatment, the characteristics of the saline placebo are often poorly reported. In addition, the saline placebo is often mixed with other excipients to more closely mimic the active intervention. </p> </section> <section id="CD012597-sec-0175"> <h3 class="title" id="CD012597-sec-0175">Agreements and disagreements with other studies or reviews</h3> <section id="CD012597-sec-0176"> <h4 class="title">Comparison with systematic reviews looking at nasal saline irrigation for allergic rhinitis </h4> <p>We found two systematic reviews. Each included both randomised and non‐randomised clinical trials (e.g. before‐after studies). The conclusions of the reviews did not contradict the findings of our review: </p> <p> <ul id="CD012597-list-0028"> <li> <p><a href="./references#CD012597-bbs2-0060" title="HermelingmeierKE , WeberRK , HellmichM , HeubachCP , MosgesR . Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta‐analysis. American Journal of Rhinology &amp; Allergy2012;26(5):e119‐25. [DOI: 10.2500/ajra.2012.26.3787] ">Hermelingmeier 2012</a>: "<i>Saline nasal irrigation (SNI) using isotonic solution can be recommended as complementary therapy in AR. It is well tolerated, inexpensive, easy to use, and there is no evidence showing that regular, daily SNI adversely affects the patient’s health or causes unexpected side effects.</i>" </p> </li> <li> <p><a href="./references#CD012597-bbs2-0062" title="KhianeyR , OppenheimerJ . Is nasal saline irrigation all it is cracked up to be?. Annals of Allergy, Asthma &amp; Immunology2012;109:20‐8. ">Khianey 2012</a>: "<i>Overall, the data appear to demonstrate some small clinical benefit to nasal saline irrigation. Nasal saline irrigation is well tolerated, with minimal side effects. Further definitive studies are needed to optimize efficacy.</i>" </p> </li> </ul> </p> </section> <section id="CD012597-sec-0177"> <h4 class="title">Comparison with Cochrane Reviews looking at nasal saline irrigation for other populations</h4> <p>We found two Cochrane Reviews investigating the use of nasal saline irrigation in other populations. Both highlighted the low quality of the evidence as a limiting factor in drawing conclusions. </p> <p> <ul id="CD012597-list-0029"> <li> <p><a href="./references#CD012597-bbs2-0054" title="ChongLY , HeadK , HopkinsC , PhilpottC , GlewS , ScaddingG , et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database of Systematic Reviews2016, Issue 4. [DOI: 10.1002/14651858.CD011995.pub2] ">Chong 2016</a> investigated nasal saline irrigation in people with chronic rhinosinusitis. The authors only found two studies with very different populations, methods of nasal irrigation and comparisons. They found that the quality of evidence was very low and that it was difficult to draw conclusions. </p> </li> <li> <p><a href="./references#CD012597-bbs2-0064" title="KingD , MitchellB , WilliamsCP , SpurlingGKP . Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD006821.pub3] ">King 2015</a> examined the use of nasal saline irrigation in people with upper respiratory tract infections (URTIs). They concluded: "<i>Nasal saline irrigation possibly has benefits for relieving the symptoms of acute URTIs. However, the included trials were generally too small and had a high risk of bias, reducing confidence in the evidence supporting this.</i>" </p> </li> </ul> </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012597-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012597-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012597-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012597-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Saline versus no saline treatment, Outcome 1 Disease severity score (up to 4 weeks)." data-id="CD012597-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Saline versus no saline treatment, Outcome 1 Disease severity score (up to 4 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Saline versus no saline treatment, Outcome 2 Disease severity score (4 weeks to 6 months)." data-id="CD012597-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Saline versus no saline treatment, Outcome 2 Disease severity score (4 weeks to 6 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Saline versus no saline treatment, Outcome 3 Health‐related quality of life." data-id="CD012597-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Saline versus no saline treatment, Outcome 3 Health‐related quality of life. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Saline versus no saline treatment (adjuvant to intranasal steroids or oral antihistamines), Outcome 1 Disease severity score (up to 4 weeks)." data-id="CD012597-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Saline versus no saline treatment (adjuvant to intranasal steroids or oral antihistamines), Outcome 1 Disease severity score (up to 4 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Saline versus no saline treatment (adjuvant to intranasal steroids or oral antihistamines), Outcome 2 Disease severity score (4 weeks to 6 months))." data-id="CD012597-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Saline versus no saline treatment (adjuvant to intranasal steroids or oral antihistamines), Outcome 2 Disease severity score (4 weeks to 6 months)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Saline versus no saline treatment (adjuvant to intranasal steroids or oral antihistamines), Outcome 3 Health‐related quality of life (4 weeks to 6 months)." data-id="CD012597-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Saline versus no saline treatment (adjuvant to intranasal steroids or oral antihistamines), Outcome 3 Health‐related quality of life (4 weeks to 6 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Saline versus steroids, Outcome 1 Disease severity score (up to 4 weeks)." data-id="CD012597-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Saline versus steroids, Outcome 1 Disease severity score (up to 4 weeks).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Saline versus steroids, Outcome 2 Disease severity score (4 weeks to 6 months)." data-id="CD012597-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Saline versus steroids, Outcome 2 Disease severity score (4 weeks to 6 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Saline versus steroids, Outcome 3 Health‐related quality of life." data-id="CD012597-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Saline versus steroids, Outcome 3 Health‐related quality of life.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Saline versus steroids, Outcome 4 Adverse effects." data-id="CD012597-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Saline versus steroids, Outcome 4 Adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup comparison ‐ volume, Outcome 1 Disease severity score (up to 4 weeks)." data-id="CD012597-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Subgroup comparison ‐ volume, Outcome 1 Disease severity score (up to 4 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup comparison ‐ volume, Outcome 2 Disease severity score (4 weeks to 6 months)." data-id="CD012597-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Subgroup comparison ‐ volume, Outcome 2 Disease severity score (4 weeks to 6 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup comparison ‐ tonicity, Outcome 1 Disease severity score (up to 4 weeks)." data-id="CD012597-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Subgroup comparison ‐ tonicity, Outcome 1 Disease severity score (up to 4 weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012597-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/urn:x-wiley:14651858:media:CD012597:CD012597-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_t/tCD012597-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup comparison ‐ tonicity, Outcome 2 Disease severity score (4 weeks to 6 months)." data-id="CD012597-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Subgroup comparison ‐ tonicity, Outcome 2 Disease severity score (4 weeks to 6 months). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/media/CDSR/CD012597/image_n/nCD012597-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012597-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Saline versus no saline treatment for allergic rhinitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Saline versus no saline treatment for allergic rhinitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> allergic rhinitis </p> <p><b>Setting:</b> secondary care<br/> <b>Intervention:</b> saline<br/> <b>Comparison:</b> no saline treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>What happens</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Without saline</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>With saline</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Difference</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease severity score (up to 4 weeks)</p> <p>Assessed with: various instruments<br/> Follow‐up: range 1 week to 4 weeks<br/> № of participants: 407 </p> <p>(322 children; 85 adults)<br/> (6 RCTs) <sup>2</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.32 lower<br/> (1.84 lower to 0.81 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline irrigation may improve the patient‐reported disease severity compared with no saline treatment in both children and adults. The mean difference in disease severity score was 1.32 standard deviations lower (1.84 to 0.81 lower) with saline compared to no saline. This translates into a decrease of approximately 1.97 points (1.21 to 2.74) on a 0‐ to 10‐point VAS for nasal symptoms (lower = better). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease severity score (4 weeks to 6 months)</p> <p>Assessed with: various instruments<br/> Follow‐up: range 6 weeks to 8 weeks<br/> № of participants: 167 </p> <p>(102 children; 65 adults)<br/> (5 RCTs) <sup>2</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.44 lower<br/> (2.39 lower to 0.48 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline irrigation may improve the patient‐reported disease severity compared with no saline treatment in both children and adults. The mean difference in disease severity score was 1.44 standard deviations lower (2.39 to 0.489 lower) with saline compared to no saline. This translates into a decrease of approximately 2.98 points (0.99 to 5.98) on a 0‐ to 10‐point VAS for nasal symptoms (lower = better). </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual symptom scores ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Epistaxis<br/> Follow‐up: range 4 weeks to 6 weeks<br/> № of participants: 240 (all children)<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Not pooled</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2 studies (240 children) reported no adverse effects in either arm. Both studies included only children. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific HRQL</p> <p>Assessed with: RCQ‐36 quality of life questionnaire<br/> Scale from: 0 to 140, lower = better<br/> Follow‐up: 4 weeks<br/> № of participants: 42 (all children)<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease specific HRQL ‐ Up to 4 weeks without saline was 19.26</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 3.32 lower<br/> (11.35 lower to 4.71 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline improves the disease‐specific quality of life at 4 weeks, compared with no saline, because the quality of the evidence is very low. The study included only children. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease‐specific HRQL ‐ 4 weeks to 6 months<br/> Assessed with: RCQ‐36<br/> Scale from: 0 to 140<br/> follow‐up: 6 weeks<br/> № of participants: 42 (all children)<br/> (1 RCT) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean disease specific HRQL ‐ 4 weeks to 6 months without saline was 15.94</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.06 lower<br/> (8.38 lower to 4.26 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline improves the disease‐specific quality of life at 6 weeks, compared with no saline, because the quality of the evidence is very low. The study included only children. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Other adverse effects: local irritation<br/> Follow‐up: range 4 weeks to 6 weeks<br/> № of participants: 240 (all children)<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>Not pooled</p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2 studies (240 children) reported no adverse effects in either arm. 3 further studies (68 children; 44 adults) reported no adverse effects in the saline arm. There is no information for the control arm. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0%</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not pooled</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>HRQL:</b> health‐related quality of life; <b>MD:</b> mean difference; <b>RCQ‐36:</b> Thai rhinoconjunctivitis quality of life scale; <b>RCT:</b> randomised controlled trial; <b>SMD:</b> standardised mean difference; <b>VAS:</b> visual analogue scale </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Low‐quality evidence. Downgraded by one level due to <b>risk of bias</b> (all of the studies used different scales for which the validation is unknown). Downgraded by one level due to <b>inconsistency</b> (there is statistical heterogeneity within the results possibly due to the variations in tonicity, volume and method of application of saline used). </p> <p><sup>2</sup>Different instruments were used to assess the disease severity score. A summary of these can be found in <a href="#CD012597-tbl-0004">Table 2</a>. </p> <p><sup>3</sup>Low‐quality evidence. Downgraded by two levels due to <b>risk of bias</b> (the reporting of the adverse outcomes was very poor and it was unclear whether the adverse effects were systematically sought). </p> <p><sup>4</sup>Very low‐quality evidence. Downgraded by two levels for <b>risk of bias</b> (results came from one study using an instrument for which the validation status is unknown with a high risk of performance and detection bias). Downgraded by one level for <b>imprecision</b> (the results are imprecise due to the small sample size and the confidence intervals are very wide). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Saline versus no saline treatment for allergic rhinitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012597-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Saline irrigation plus pharmacological treatment versus pharmacological treatment alone for allergic rhinitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Nasal saline plus pharmacological treatment versus pharmacological treatment alone for allergic rhinitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> allergic rhinitis </p> <p><b>Setting:</b> secondary care<br/> <b>Intervention:</b> saline plus pharmacological treatment (intranasal steroids or oral antihistamines)<br/> <b>Comparison:</b> pharmacological treatment alone </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>What happens</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Without saline</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>With saline</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Difference</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease severity score (up to 4 weeks)</p> <p>Assessed with: various instruments used</p> <p>Follow‐up: 4 weeks</p> <p>№ of participants: 32 (18 children; 14 adults)</p> <p>(2 RCTs)<sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.6 lower</p> <p>(1.34 lower to 0.15 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline in addition to pharmacological treatment (antihistamines or steroids) improves patient‐reported severity scores at 4 weeks, compared with pharmacological treatment alone. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Disease severity score (4 weeks to 6 months)<br/> Assessed with: various instruments used<br/> Follow‐up: 3 months<br/> № of participants: 58 (18 children; 40 adults)<br/> (2 RCTs) <sup>1</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 0.32 lower</p> <p>(0.85 lower to 0.21 higher)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline in addition to pharmacological treatment (antihistamines or steroids) improves patient‐reported severity scores at 3 months, compared with pharmacological treatment alone. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual symptom scores ‐ not measured</p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse effects ‐ epistaxis</p> <p>№ of participants: 58 (2 RCTs)</p> <p>(18 children; 40 adults)</p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Three studies made statements about adverse effects. One study (40 adults) indicated that "<i>all [treatments were] tolerated well, none [of the participants] had adverse events</i>" (<a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>) and the other two studies (62 children) reported that nasal irrigation with saline was well accepted in all patients and no adverse effect was reported with the use of saline (<a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether there is a difference in adverse effects between the groups. None of the studies specifically mentioned epistaxis as an adverse effect. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life (4 weeks to 6 months)</p> <p>Assessed with: various instruments</p> <p>№ of participants: 54 (all adults)</p> <p>(2 RCTs)<sup>4</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD 1.26 lower</p> <p>(2.47 lower to 0.05 lower)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether saline in addition to pharmacological treatment (antihistamines or steroids) improves health‐related quality of life at 4 weeks to 6 months, compared with pharmacological treatment alone. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Other adverse effects: local irritation<br/> Follow‐up: range 4 weeks to 6 weeks<br/> № of participants: 58 (18 children;40 adults)<br/> (2 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>None of the studies specifically mentioned local irritation as an adverse effect. Two studies made statements about adverse effects. One study (40 adults) indicated that "<i>all [treatments were] tolerated well, none [of the participants] had adverse events</i>" (<a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a>) and the other (18 children) that "<i>Nasal irrigation with saline was well accepted in all patients and no adverse effect was reported</i>” (<a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a>). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is uncertain whether there is a difference in adverse effects between the groups as no adverse effects were reported. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>SMD:</b> standardised mean difference </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Different instruments were used to assess the disease severity score. A summary of these can be found in <a href="#CD012597-tbl-0004">Table 2</a>. </p> <p><sup>2</sup> Very low‐quality evidence. Downgraded by two levels due to <b>risk of bias</b> (studies were generally poorly conducted with a high risk of bias; the validation status of the symptom severity scores used is unknown). Downgraded by one level due to <b>imprecision</b> (the results are imprecise with small sample sizes and wide confidence intervals). </p> <p><sup>3</sup>Very low‐quality evidence. Downgraded by two levels due to <b>risk of bias</b> (studies were generally poorly conducted with a high risk of bias and it is unclear whether adverse effects were systemically reported). Downgraded by one level due to <b>imprecision</b> (very small sample size). </p> <p><sup>4</sup><a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a> used the 'Global Impact' score for the Rhinasthma quality of life instrument. <a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> used the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) but the range of possible scores is not reported. </p> <p><sup>5</sup>Very low‐quality evidence. Downgraded by two levels due to <b>risk of bias</b> (studies were generally poorly conducted with a high risk of bias; it is unclear whether the instruments used were validated and the scale in one remains unknown). Downgraded by one level due to <b>inconsistency</b> (there is significant statistical heterogeneity between the results). Downgraded by one level due to <b>imprecision</b> (sample size is very small and so the confidence intervals are very wide). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Saline irrigation plus pharmacological treatment versus pharmacological treatment alone for allergic rhinitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012597-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study characteristics</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Population</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign="top"> <p><b>Intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Comparison</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Severity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intermittent/ persistent</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Allergen</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Tonicity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Volume<sup>1</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Administration methods</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adjuvant</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment duration</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a> (Thailand) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mild/moderate</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated (persistent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>House dust mite, cockroach, cat, dog, grass, moulds</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Normal'/isotonic saline</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 mL</p> <p>(high)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day using Hashi® Nasal Rinser</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If needed: cetirizine and pseudoephedrine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate/severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>House dust mites and mould</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (sea water)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 to 6 sprays, 2 times per day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200 μg fluticasone propionate nasal spray daily</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a> (USA) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>21</p> <p>Adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Seasonal</p> <p>(intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pollen and <i>Alternaria</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Hypertonic Dead Sea saline spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sprays, 3 times per day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aqueous triamcinolone spray (110 μg into each nostril once daily)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2. Normal saline spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sprays, 3 times per day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aqueous triamcinolone spray (110 μg into each nostril once daily)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> <p>Adults</p> <p>(allergic rhinoconjunctivitis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grass pollen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (% not given)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15 mL</p> <p>(very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, using a nasal aerosol spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 days</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Parietaria</i> pollen </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (3%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2.5 mL</p> <p>(very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day, using disposable syringe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> <p>Children</p> <p>(allergic rhinoconjunctivitis)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Grass pollen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (3%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.15 mL</p> <p>(very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day, spray from bottle fitted with an atomiser</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44</p> <p>Adults</p> <p>(pregnant women)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Parietaria</i> pollen </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (3%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 mL</p> <p>(low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 times per day, using disposable syringe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>26</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate/severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>House dust mites and mould</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>'Normal' (0.9%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>500 mL</p> <p>(high)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day using positive‐pressure nasal irrigation applicator</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256 μg budesonide nasal spray daily</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day using positive‐pressure nasal irrigation applicator</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> <p>Adults (allergic rhinitis with chronic cough)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>House dust mites</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Normal' (0.9%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100 mL</p> <p>(high)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal pharyngeal irrigation (pumping saline solution from a solution bag hung on a drip stand overhead into each nostril and allowing it to run out of the mouth) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>220</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Seasonal (intermittent)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Grass pollen including orchard and rye grass</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Hypertonic (2.7%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 mL</p> <p>(low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, irrigation using bulb syringe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2. 'Normal' (0.9%)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20 mL</p> <p>(low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, irrigation using bulb syringe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rescue antihistamines</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>30</p> <p>Adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Moderate/severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mugwort pollen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated: 1 'puff' (very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2 times per day, using a nasal aerosol spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No saline treatment</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Budesonide, 128 µg per nostril per day</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a> (Italy) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14</p> <p>Adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>House dust mites and/or <i>Parietaria</i> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertonic (% not given)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cetirizine, orally, 10 mg/day</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antihistamines alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> (China) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61</p> <p>Adults</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>'Normal' (% not given)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>75 mL</p> <p>(high)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, no method given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Budesonide, intranasal steroid spray, 64 µg/spray, 1 spray twice day (in morning and at night) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 times per day, no method given</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0014" title="YasarM , UysalIO , AltuntasEE , CevitO , MuderrisS . Effects of topical sprays on allergy‐induced nasal obstruction in children. Kulak Burun Bogaz Ihtisas Dergisi: KBB [Journal of Ear, Nose, and Throat]2013;23(4):217‐24. ">Yasar 2013</a> (Turkey) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> <p>Children</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mild, moderate and severe</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Persistent and seasonal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> <p>"2 puffs"</p> <p>(very low)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 'puffs' per nostril per day, using a nasal aerosol spray</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mometasone furoate (2 puffs in each nostril per day)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 weeks</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Steroids alone</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p><sup>1</sup>Volume reported as per nostril per application. The volume categories were defined as: VERY LOW: less than 5 ml per nostril per application; LOW: between 5 ml to 59 ml per nostril per application; HIGH: ≥ 60 ml per nostril per application. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of study characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012597-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of patient‐reported disease severity scores</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Symptoms measured</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Score for each symptom</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Summation (total range)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Notes</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0001" title="ChairattananonC , PensrichonR , VeskitkulJ , PacharnP , PiboonpocanunO , VisitsunthornN , et al. Efficacy of saline nasal irrigation in children with allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology2013;68:359. ">Chairattananon 2013</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>'Nasal symptoms'</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Visual analogue scale</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed once at end of study (0 to 10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score = worse symptoms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0002" title="ChenJR , JinL , LiXY . The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. International Journal of Pediatric Otorhinolaryngology2014;78(7):1115‐8. ">Chen 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 3 scale</p> <p>(0 = no symptoms, 3 = severe symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total scores represented the sums of scores for the 4 symptoms (range: 0 to 12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No measures of variance presented and insufficient details to impute them.</p> <p>Authors were contacted but no response was received.</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0003" title="CordrayS , HarjoJB , MinerL . Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear, Nose, &amp; Throat Journal2005;84(7):426‐30. ">Cordray 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p>Not measured</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0004" title="DiBerardinoF , ZanettiD , D'AmatoG . Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. American Journal of Rhinology &amp; Allergy2017;31(1):40‐3. ">Di Berardino 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Nasal discharge</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 2 scale (0 = no symptoms, 2 = intolerable symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily scores for each symptom were added together then summed for each day of the 7‐day trial period (range: 0 to 56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0005" title="AngrisanoA . Hypertonic saline nasal wash: effect on grass pollen rhinitis in children. Allergy and Clinical Immunology International2003;1(Suppl 1):P‐16‐4. GaravelloW , RomagnoliM , SordoL , GainiRM , DiBerardinoC , AngrisanoA . Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatric Allergy and Immunology2003;14(2):140‐3. ">Garavello 2003</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 4 scale (0 = no symptoms, 4 = worst symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily scores for each symptom were summed. The daily scores were averaged to calculate 'mean daily rhinitis score' per participant for each week (range: 0 to 16). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0006" title="GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM . Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. International Archives of Allergy and Immunology2005;137(4):310‐4. GaravelloW , DiBerardinoF , RomagnoliM , SambataroG , GainiRM , et al. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Proceedings of the 9th International Conference on Pediatric Otorhinolaryngology (ESPO), Paris, France, 18‐21 June 2006. 2006:Abstract No. 369. ">Garavello 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal discharge</p> <p>2. Nasal blockage</p> <p>3. Eye redness</p> <p>4. Eye itching</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 3 scale (0 = none, 3 = severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily scores for each symptom were summed. The daily scores were averaged to calculate a 'mean daily rhinitis score' per participant for each week of the pollen season (probable range: 0 to 12, see notes section). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Paper reports that the total range was 0 to 16. Authors were contacted for clarification but there was no response. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0007" title="GaravelloW , SomiglianaE , AcaiaB , GainiL , PignataroL , GainiRM . Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. International Archives of Allergy and Immunology2010;151(2):137‐41. ">Garavello 2010</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 4 scale (0 = none; 1 = slight; 2 = mild; 3 = moderate; 4 = severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Daily scores for each symptom were summed. The daily scores were averaged to calculate a 'mean daily rhinitis score' per participant for each week of the pollen season (range: 0 to 16). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0008" title="LiH , ShaQ , ZuoK , JiangH , ChengL , ShiJ , et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL; Journal for Oto‐rhino‐laryngology and Its Related Specialties2009;71(1):50‐5. ">Li 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Sneezing/itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal congestion</p> <p>4. Postnasal drip/snorting</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 3 scale (0 = no symptom)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Individual symptom scores were summed to give a total score (range: 0 to 12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0009" title="LinL , ChenZ , CaoY , SunG . Normal saline solution nasal‐pharyngeal irrigation improves chronic cough associated with allergic rhinitis. American Journal of Rhinology &amp; Allergy2017;31(2):96‐104. ">Lin 2017</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal obstruction</p> <p>2. Rhinorrhoea</p> <p>3. Sneezing</p> <p>4. Nasal pruritis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Visual analogue scale</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Completed once at end of study (0 to 10)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lower score = less severe symptoms</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0010" title="MarchisioP , VarricchioA , BaggiE , BianchiniS , CapassoME , TorrettaS , et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. International Journal of Immunopathology and Pharmacology2012;25(3):721‐30. ">Marchisio 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal itching</p> <p>2. Rhinorrhoea</p> <p>3. Nasal obstruction</p> <p>4. Sneezing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 4 (1 = no symptoms, 4 = severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nasal score was calculated as the mean of the sum of scores of each nasal symptom (range: 1 to 4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rhinorrhoea was assessed by physician</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0011" title="NingX , XingZ , WangM , GaoZ . To investigate the effect of pretreatment with budesonide spray in patients with allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2011;25(14):633‐5. ">Ning 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Sneezing</p> <p>2. Rhinorrhoea</p> <p>3. Blocked nose/congestion</p> <p>4. Itchy nose</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 3 (higher = worse symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom score was calculated as the sum of the individual symptoms (range: 4 to 12)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0012" title="RogkakouA , GuerraL , MassacaneP , BaiardiniI , Baena‐CagnaniR , ZanellaCH , et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis‐‐a randomized controlled study. European Annals of Allergy and Clinical Immunology2005;37(9):353‐6. ">Rogkakou 2005</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Rhinorrhoea</p> <p>2. Itching</p> <p>3. Sneezing</p> <p>4. Stuffy nose</p> <p>5. Watery eyes</p> <p>6. Itching</p> <p>7. Conjunctival hyperaemia</p> <p>8. Palpebral oedema</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4‐point scale (0 = none, 3 = severe)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The sum of the symptom scores for each week of the study was calculated (range: 0 to 24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Night‐time symptom scores were also reported by participants but not presented in this review </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD012597-bbs2-0013" title="WuM , WangQ , ZhangK , WuK , ZhangY , WangZ , et al. The effect of nasal irrigation in the treatment of allergic rhinitis. Lin Chuang Er Bi Yan Hou Ke za Zhi [Journal of Clinical Otorhinolaryngology]2014;28(5):287‐9. ">Wu 2014</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1. Nasal obstruction</p> <p>2. Itching</p> <p>3. Sneezing</p> <p>4. Nasal discharge</p> <p>5. Eye itching</p> <p>6. Eye swelling</p> <p>7. Tearing</p> <p>8. Eye pain</p> <p>9. Coughing</p> <p>10. Difficulty breathing</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 to 10 (0 = least symptoms, 10 = most symptoms)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The method for combining is not clear. The results are likely to be an average of the individual symptoms (range: 0 to 10). </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of patient‐reported disease severity scores</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/full#CD012597-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012597-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Saline versus no saline treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Disease severity score (up to 4 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.32 [‐1.84, ‐0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>322</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.07 [‐1.39, ‐0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐3.80, ‐0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disease severity score (4 weeks to 6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.44 [‐2.39, ‐0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.06 [‐2.13, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.02 [‐3.79, ‐0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Health‐related quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Up to 4 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.32 [‐11.35, 4.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 4 weeks to 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.06 [‐8.38, 4.26]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Saline versus no saline treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012597-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Saline versus no saline treatment (adjuvant to intranasal steroids or oral antihistamines)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Disease severity score (up to 4 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.34, 0.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Steroids as adjuvant treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐1.31, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Antihistamines as adjuvant treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.95 [‐2.08, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disease severity score (4 weeks to 6 months)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.85, 0.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Steroids as adjuvant treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.85, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Health‐related quality of life (4 weeks to 6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.26 [‐2.47, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Steroids as adjuvant treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐1.43, ‐0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Antihistamines as adjuvant treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.05 [‐3.43, ‐0.67]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Saline versus no saline treatment (adjuvant to intranasal steroids or oral antihistamines)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012597-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Saline versus steroids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Disease severity score (up to 4 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [‐1.65, 3.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disease severity score (4 weeks to 6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [‐0.92, 3.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Health‐related quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.73, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.00, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Saline versus steroids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012597-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup comparison ‐ volume</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Disease severity score (up to 4 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.32 [‐1.84, ‐0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Very low‐volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.96 [‐1.39, ‐0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Low‐volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.07 [‐3.73, ‐0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 High‐volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.92 [‐1.56, ‐0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disease severity score (4 weeks to 6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.44 [‐2.39, ‐0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Very low‐volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.33 [‐2.22, ‐0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Low‐volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.91 [‐3.77, ‐2.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 High‐volume</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐1.02, 0.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup comparison ‐ volume</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012597-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Subgroup comparison ‐ tonicity</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Disease severity score (up to 4 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>407</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.45 [‐2.13, ‐0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Physiologic (0.9% saline)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.82 [‐1.18, ‐0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Hypertonic (&gt; 0.9% saline)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.72 [‐2.62, ‐0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Disease severity score (4 weeks to 6 months) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.52 [‐2.70, ‐0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Physiologic (0.9% saline)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐1.02, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Hypertonic (&gt; 0.9% saline)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.91 [‐3.14, ‐0.68]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Subgroup comparison ‐ tonicity</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012597.pub2/references#CD012597-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012597.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012597-note-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012597-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012597-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012597-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD012597-note-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD012597-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012597-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012597-note-0006">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012597-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD012597-note-0011">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012597-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012597-note-0016">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012597\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012597\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012597\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012597\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012597\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=qy4lqFNF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012597.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012597.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012597.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012597.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012597.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728927236"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012597.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728927241"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012597.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ed06c98879368',t:'MTc0MDcyODkyNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 